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ABSTRACT OF THE DISSERTATION

The Effects of Advancing Age on ER Calcium Regulation in Rat Superior Cervical
Ganglia
by
Con win Kodel Vanterpool

Doctor of Philosophy, Graduate Program in Physiology and Pharmacology
Loma Linda University, June 2006
Dr. John Buchholz

Intracellular calcium ([Ca2+]i) release from endoplasmic reticulum (ER)
stores plays an important role in cell signaling. These stores are rapidly refilled via
voltage-gated calcium channels or spontaneously via store-operated calcium channels and
subsequent pumping by ER Ca2+-ATPases. Calcium release is triggered by the activation
of the ryanodine receptor (RyR) channels and their function is in part dependent on their
expression. We analyzed the [Ca2+]i transients in fura 2-loaded superior cervical ganglion
(SCG) cells from 6, 12, 20, and 24-month-old Fischer 344 rats for their ability to rapidly
and spontaneously refill. For rapid refilling, the percent difference between the peak and
*

rate of rise of the first and second caffeine-evoked [Ca2+]i transient significantly declined
with age. Spontaneous refilling significantly declined from 12-24 month-old F-344 rats.
These data suggest that the ability of SCG cells to sustain release of [Ca2+]i decline with
age, but the underlying mechanisms that may be responsible for a decline in caffeineevoked release of Ca2+ remain elusive.

Hence, we then focused on molecular

characterization of the [Ca2+]i release channel. The pattern of genetic expression of
RyRl, 2 and 3, has not been previously characterized with age in this model. In all age

xii

groups ryr 1 does not appear to be expressed in the SCG and ryr2 and ryr3 appear to be
the predominantly transcribed isoforms in adult rat SCG. mRNA and protein levels for
RyR2 did not change with age, however, the ryr3 mRNA and protein levels significantly
increased from 6 to 12 months and then significantly declined from 12 to 24 months.
These data alone, cannot account for the dramatic decline in caffeine-evoked Ca2+ release
observed. However, if along with the changes in gene expression there was altered
modulation, this may elucidate more clearly the reasons for the change in function of the
RyR. In order to examine how the modulation of the RyR is affected by age, we then
focused on modulators such as phosphorylation, and nNOS protein expression levels
were analyzed for changes with age. There were no significant changes in the
phosphorylation of the total RyRs with age. However, there was a significant increase in
nNOS production from 6 months to 12 months and decline in protein expression of nNOS
from the 12 months to 24 month-old rat SCG. We have demonstrated that aging
significantly impacts the ability of the SCG to sustain calcium release, and exhibits
altered genetic and protein expression of the major RyR isoforms, and nNOS protein
expression. Taken together, these data suggest that the alteration in release of Ca2+ is due
to a combination of altered filling of the ER and changes in the modulation of the release
mechanism. The compromised ability of these neurons to sustain calcium signaling may
possibly

alter

the

overall

function

of

cerebro vasculature.

xiii

adrenergic

neurons

innervating

the

CHAPTER ONE
INTRODUCTION
Innervation of the cerebro-vasculature by adrenergic neurons arising from the
superior cervical ganglia (SCO), curtails increased cerebral blood flow that may arise as a
result of hypertension (20; 47; 53; 68; 144). Thus, these neurons may play an increased
role in reducing the risk of stroke due to blood brain barrier displacement in the face of
hypertension. SCO function depends on the release of calcium from the endoplasmic
reticulum (ER). This occurs by a process called calcium induced calcium release (CICR)
(11; 12; 26; 96; 142; 150; 154). CICR amplifies increases in intracellular calcium
([Ca2+]i) caused by influx through calcium channels (148-150). The goal of this project is
to understand the mechanism(s) underlying age-related changes in [Ca2+]i signaling in
adrenergic neurons arising from the SCO. Preliminary and published studies with our
SCO neuronal model show that age decreases (1) the ability of rat SCO cells to sustain
Ca2+ release from the ER, (2) the fast refilling and the rate of spontaneous refilling of
caffeine-inducible intracellular calcium stores, (3) smooth endoplasmic reticulum Ca2+
ATPase (SERCA) function (17; 40; 41; 115-119; 152). These findings suggest that at
least two mutually dependent mechanisms contribute to an age-related decline in CICR:
(1) decreased filling of ER and (2) possible changes in the function of the ER Ca2+
release mechanism.

1

Intracellular Calcium: A universal second messenger
Calcium is a ubiquitous intracellular second messenger (10). At rest, cells
maintain an intracellular calcium concentration at much lower levels than what is found
extracellularly. By opening calcium selective pores, calcium is allowed to flow from
outside of the cell into the cytosol, or is released from specialized intracellular calcium
([Ca2+]i) stores by CICR. Cerebrovascular adrenergic nerves rely on this process to
function (Figure 1.1). CICR mobilizes Ca2+ from the ER in response to an elevation in
[Ca2+]i mediated by voltage-gated Ca2+ channels. CICR is relevant in processes such as
release of neurotransmitters and hormones, secretion, contraction, and alterations in
membrane excitability (55; 121; 149; 150). Since [Ca2+]i is such a universal component
for so many cellular processes, deregulation could lead to problems of devastating
proportions.
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A. Model of CICR in Neurons
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Figure 1.1. Model of CICR in sensory neurons (adapted from (150). Five electrical
pulses (blue line) induce influx of Ca2+ via Ca2+ channels. [Ca2+]i is rapidly buffered by
Ca2+ binding proteins inducing a small increase in [Ca2+]i. With 7 pulses (red line)
[Ca2+]i rises to a "threshold" resulting in CICR and the development of a full [Ca2+]i
transient. With 11 pulses (green line) a transient similar to 7 pulses (red line) develops
with no further increase in [Ca ]i. Thus, seven pulses or greater increases [Ca ]i to a
"threshold" that triggers CICR. CICR to Ca2+ is subject to modulation via the levels of
cADPr (81; 140). The levels of cADPr are in turn modulated via the NO/guyanylate
cycles/cGMP-PKGi pathway (33; 79).
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Transmitter release, plasticity and excitability
Calcium plays a crucial role in neuronal excitability and transmitter release (11;
34; 111; 154). Within neurons, an important source of calcium is found within the ER
(11). The ER is formed by an elaborate network of endomembranes, and is found in all
neurons (154). One of the roles of the ER is to monitor internal signals like Ca2+, IP3,
cyclic ADP ribose, and cyclic AMP, via receptor protein complexes found on its
membrane (10-12; 16; 43; 82). In addition, this organelle can produce signals using
calcium released through the IP3 and ryanodine receptors (RyR) located on its membrane.
The trigger for exocytosis of neurotransmitters has been classically believed to be due to
voltage-dependent calcium entry, but increasing evidence points to the ER’s involvement
in some forms of neurotransmission (9-12). Efflux of Ca2+ from the ER has also has
been implicated in different aspects of excitability. It can stimulate neurotransmitter
release and promote membrane excitability, and when in close proximity to the plasma
membrane can activate Ca2+ activated K+ channels, which hyperpolarizes the cell
membrane inhibiting this process. So the ER not only participates in, but also modulates
neuronal excitability.
Cell death
There have been debates on the involvement of calcium in the regulation of cell
death. Intrinsic apoptosis can occur by contributions of the mitochondria, plasma
membrane, or the endoplasmic reticulum. Which pathway predominates depends on the
cell type (164). It has been demonstrated that persistent ER stress induces apoptosis. Rao
et. al. 2001 demonstrated that procaspase 12, involved in ER-stress induced apoptosis,
can become cleaved and activated after calcium is released from the ER (124). The
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translocation of caspase-7 from the cytoplasm to the ER also occurs in a calciumdependent manner. In has also been reported that in breast epithelial cells, the over
expression of Bcl-2, an anti-apoptotic protein, results in an up-regulation of SERCA2
mRNA expression. This over expression would result in increased Ca2+ uptake in the ER,
which may prevent Ca2+ mediated apoptosis from occurring.
ER/SR Ca2+ homeostasis and intracellular Ca2+ handling
Releasing [Ca2+]i from internal stores, and refilling these stores is vital for
sustaining many cellular processes. This delicate regulation of [Ca2+]i demonstrates the
importance of the SERCA pump and the RYR channel’s function. This balance suggests
that CICR and [Ca2+]i buffering are intimately related processes (154; 155) For example
in SCG and sensory neurons, ER Ca2+ stores can be rapidly refilled by depolarization
with high K+ or spontaneously refill within 3-10 min following depletion with caffeine
(51; 52; 149; 150; 155); Depletion of ER Ca2+ stores with repeated exposure to caffeine
will prohibit CICR, and is attenuated by the application of a SERCA antagonist to reduce
refilling of ER Ca2+ stores (51; 52; 89; 148). In summary, adrenergic nerves play an
important role in regulating cerebral blood flow in response to rising blood pressure.
CICR represents a modulator of transmitter release, and modulators of the CICR process
such as NO released from NOS-containing, nerves can modulate transmitter release itself
(98). This modulation of CICR by NO occurs through the NO guanylate cyclase/cGMPdependent PKGi/cADPr pathway (33) (Figure 1.2).

5

Nitric oxide

\
cGMP

\
G-kinase
ADP-ribosyl cyclase
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♦
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Figure 1.2. Modulation of RyR by nitric oxide. cADPR has been shown to play a role
in the modulation of the RyR. It is modulated by nitric oxide via nNOS, through the nitric
oxide (NO), guanylate cyclase, cyclic guanosine monophoshate (cGMP), cGMPdependent protein kinase-1 (PKGi), cADPr pathway which can stimulate CICR.

6

Ca2+ channels and pumps of the ER/SR
Ryanodine receptor calcium release channels
Structure and function
RyR channels are located on the membrane of the ER. These receptors have been shown
to be responsible for calcium release from stores found in the ER (11; 32; 48; 49). The
RyR monomer is approximately 565 kDa. Cryoelectron microscopy and 3D
reconstruction studies demonstrated that the RyRs is an assembly of four monomers
forming a tetramer (36; 158). These tetramers have been reported to be either homo or
hetero tetramers (36). It has been demonstrated that monomers of RyR2 can form
tetramers with monomers of RyR 1 or RyR3; however, monomers of RyR3 can only form
tetramers with monomers of RyR2, not RyRl.
Different isoforms
In mammalians, there are three major isoforms of the RyR family (13; 33; 36; 48; 49;
101). The three isoforms (RyRl, RyR2, and RyR3) are encoded by three different
chromosomes (126). The expression of the RyRs are different in different cell types (36;
42; 48; 154). In skeletal muscle, RyRl has been reported to be the major isoform
expressed and is referred to as the skeletal muscle isoform (48; 49; 131). RyR2 has been
reported to be abundant in cardiac muscle and is therefore referred to as the cardiac
isoform [Reviewed in (48; 49)]. RyR3 has been found in skeletal muscles in low levels,
but it was first shown to be expressed in neuronal tissue and have been termed the brain
type (48; 104; 141). The role of RyR3 is currently being studied in the different tissues.
It has been reported that mice lacking RyRl or RyR2 die during the embryonic stage
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(137; 139), where as the mice lacking RyR3 live, but CICR in the skeletal muscle has
been impaired (48), more investigation on its specific role is needed.
Endogenous modulators ofRyRs
Ca2+
Both cytosolic and luminal calcium has been shown to modulate the function of the RyR
channels. The RyR have been shown to be activated by low levels of cytosolic calcium
(1-10 /xM) and inhibited by high concentrations (1-10 mM) (48). Reports show that RyR2
and RyR3 respond at a greater magnitude to cytosolic calcium than the RyRl isoform
(19; 31; 35). Luminal calcium levels have been demonstrated to affect RyR function by
interacting with the luminal binding sites and binding to luminal proteins (48). These
findings however are still controversial in relevance to physiological roles.
ATP and Mg 2+
Cytosolic ATP has been shown to be very important in the RyR channel activation. ~ 300
/xM concentrations of free cytosolic ATP has demonstrated to activate the RyR channels
(48). Mg2+ has also been shown to play a role in regulating the receptors. It has been
shown to be a potent inhibitor of the channels by competing with calcium at calcium
binding sites (48). Reports have indicated that the RyRl is more sensitive to activation by
physiological calcium levels and inhibition by magnesium levels in comparison to RyR2
and RyR3 isoforms (35; 36; 48).
Redox potential and Nitric Oxide
The RyR channels have been shown to contain approximately 80-100 cysteine residues
indicating that these sites can be modified by oxidants (136; 138). Selected sulfurhydryl
groups present on the RyR are sensitive to the redox state. Alteration of the redox state
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can inhibit the binding of calmodulin, a calcium binding protein, to the RyR. This
disruption can result in the alteration of calmodulin’s ability to activate or inhibit the RyR
channel function depending on calcium concentration. (48). It has been documented that
nitric oxide (NO), an oxidant, can also regulate the RyR channels (48). Initial release of
nitric oxide has been shown to activate the RyR channels and subsequent increases in NO
levels can inhibit the activity of the RyR channels (60).Recent studies indicated the
biochemistry of this facilitation is through S-nitrosylation of the RyR channel which can
affect calmodulin binding to the receptor (45). Earlier studies demonstrated that the
cGMP pathway may be involved (46), which can modulate cADPr. However later
studies suggest that this occurs via a cGMP-independent pathway (45). More studies
are currently being pursued in this area.
Phosphorylation/dephosphorylation
Analysis of the RyR protein identified many consensus phosphorylation sites (48).
Kinases such as protein kinase A (PKA) was shown to activate RyRl. Calmodulin kinase
(CaMK) was also shown to phosphorylate the RyRl leading to channel activation, but
both PKA, and CaMK also have contradictory reports in the activation of RyRl (37; 48).
Further, studies on PKA, and CaMK on phosphorylating and activating RyR2 were also
showed (151). It has been suggested that phosphorylation actually stabilizes the RyR
channel to open via the ability to dissociate FKBP, which is a RyR binding protein
(discussed below) (93). These studies are also debated, adding further mystery as to the
exact roles PKA and CaMK play in modulating the RyRs.
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Calmodulin
Calmodulin has been one of the first reported proteins to interact with the RyR
[Reviewed in(48)]. Studies have shown that at low calcium levels, calmodulin can
activate the RyRl and RyR3 channels or inhibit the channels at high calcium
concentrations [Reviewed in (48; 48; 49)]. Hamilton et al has further demonstrated that
calmodulin can also inhibit RyRl by binding DHPR, disrupting the DHPR-RyRl
complex (48). It has also been reported that calmodulin cannot activate, but only inhibit
the RyR2 isoform [Reviewed in (48; 49)]. In addition, recent studies indicate calmodulin
can indirectly modulate the RyRs via the modulation of nNOS as calcium levels can
regulate calmodulin’s modulation of nNOS. In reviewing the role of calmodulin, it has
also been shown that oxidation of selective residues of the RyR can affect the binding of
calmodulin to the RyR and other reports suggests that calmodulin can protect the RyRs
during increased periods of oxidative stress (59). There are some debates, but it appears
that calmodulin has a dual role in modulating the RyR channel, and can influence its
modulation through other pathways.
Calsequestrin
Calsequestrin is a calcium binding protein that can bind a high number of calcium
molecules (7). It has also been shown to be the major calcium binding protein in the ER,
and that changes in calsequestrin due to calcium and pH can affect or modulate the RyR
(7; 48). There are however some controversial debates over the role of calsequestrin in
RyR modulation, because it has been suggested that calsequestrin has to be bound to
triadin in order to modulate the channels function (171). Further studies will have to be
performed to determine how exactly calsequestrin regulates the channels.

10

FKBP
There are great controversies on the mechanisms of how the FKBPs modulate RyR
function. It has been shown that the FKBP 12 and FKBP 12.6 can associate with all three
isoforms of the RyRs (48; 143). Four FKBPs can bind a single RyR channel. Their role in
binding the RyR’s has been the topic of debate. One group suggested that the removal of
FKBP promotes the subconductance states of the receptors, but others reported no
changes in the subconductance states (2; 3). Others have reported that the FKBPs can
stabilize the RyRs (48). It has also been reported that the FKBPs may synchronize the
function of the surrounding RyRs allowing simultaneous opening and closing of the RyR
channels (92). Debates of how these binding proteins could both stabilize and
synchronize the action of the RyRs are still current.
Smooth Endoplasmic Reticulum Calcium (SERCA) pumps
Structure and function
SERCAs have been shown to play a very crucial role in the calcium homeostasis in cells.
These calcium pumps maintain homeostasis via helping to return cytosolic calcium levels
to normal resting levels after increases in [Ca2+]i, and help to maintain a high level of
luminal calcium levels as well as high levels in the Golgi and other components of the
secretory pathway to maintain normal cellular processes [Reviewed in (91; 164)]. This
will be discussed in more detail below
Isoforms of SERCA
There are three different isoforms of SERCA, each isoform having variants [Reviewed in
(91; 120; 164)]. SERCA 1 has two variants, SERCAla/b. SERCA1 has been shown to be
mainly expressed in fast-twitch skeletal muscle fibers. SERCA2 also has two isoforms,
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SERCA2a/b. [Reviewed in (91; 120; 164)]. The SERCA2a isoform has been shown to
mainly be expressed in cardiac muscle and slow-twitch skeletal muscle. SERCA2b has
been found to be expressed in different cell types at various concentrations and it has
been said to posses a house keeping function in many tissues [Reviewed in (91; 120;
164)]. SERCA3 is the most recently discovered isoform out of all the isoforms. It has five
different variants, SERCA3a-e. This isoform is shown to have both different structures
and functions than the other isoforms [Reviewed in (91; 120; 164)]. All of the variants of
this isoform has been shown to have a 5-fold less affinity for cytosolic calcium and
require a slightly higher pH for function in comparison to the other isoforms (164). In
addition, it is not regulated by phospholamban (PEL) (90; 113; 164). It has been
suggested that their low affinity for calcium allows them to be activated in the presence
of high calcium levels. This isoform has been found in a variety of tissues including:
neurons, endothelial and secretory epithelial cells, trachea, salivary glands, endocrine
cells and white blood cells. SERCA3 appears to co-exist with SERCA2b which has been
suggested to also have house keeping function. In contrast to SERCA2b, SERCA3 has
been suggested to perform only a subsidiary role in Ca2+ homeostasis and signaling
[Reviewed in (120; 164)].
SERCA in ER stress and apoptosis
Under stressful conditions in the ER, such as disturbances in ER redox states, glucose
depravation, altered calcium regulation, and viral infection (166), a process called the
unfolding protein response (UPR) occurs (164; 166). The unfolding of proteins in the ER
prevents proper post-translational modifications of vital functional proteins from
occurring. This leads to an accumulation of misfolded or damaged proteins in the ER,
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which can lead to apoptosis (44). There are debates on how exactly the ER plays a role in
apoptosis (12), but previous studies have demonstrated that the luminal calcium in the ER
is directly linked to apoptosis in contrast to the cytosolic calcium (164). Studies have
implicated the pro-apoptotic members of the Bcl-2 family of proteins in the increase
leaking of ER Ca2+, since they have structural similarities to bacterial pore forming
proteins. This enables Bcl-2 to assemble in the membrane of the ER acting as an ion
channel (166). Other Studies have linked the anti-apoptotic members of the Bcl-2 family
to cell survival, by interaction with SERCA2b (39; 164). Though still controversial, it is
believed that the anti-apoptotic Bcl-2 members reduce SERCA2b function, preventing
complete Ca2+ store filling. This essentially reduces the amount of Ca2+ that can be
released in order to trigger apoptosis. The actions of SERCA2b are thought to be celltype specific (166). Some studies report increased activity of SERCA2b during ER stress.
In this case, it is thought that apoptosis is avoided by maintaining cell proliferative levels
of [Ca2+]i (73). This area of research is still controversial and more studies are being done
in this area.
SERCA and cell growth
There have been some debates about whether SERCA2 can regulate the growth of cells.
Most studies show that there is a correlation between filling states of calcium pool and
cell growth rate(164). It has been shown that disruption of the SERCA2 function results
in decreased cell proliferation. In other cell types, blocking calcium pumps resulted in
cell proliferation (164). From the scientific pool of evidence, it is clear that SERCA
function plays a role in cell growth. However, to what degree and in which cell types is
still under debate
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Pharmacological modulators of ER/SR associated Ca2+ pumps and channels
SERCA
Thapsigargain
Thapsigargin is an antagonist of SERCA pumps, and is isolated from the roots and fruit
of the Mediterranean umbelliferous plants (75). It blocks SERCA pumps by locking
them in their Ca2+ free conformation by forming a dead-end complex with them (66; 67).
Since SERCA function is important for RyR function, Thapsigargin can also indirectly
affect RyR function (75).
Cyclopiazonic acid
Cyclopeazonic acid (CPA) also antagonizes SERCA pumps, and it is produced by some
strains of the molds Penicillium cyclopuim and Aspergillus flavus (65). CPA decreases
SERCA affinity for ATP (75). This inhibits the enzymatic hydrolytic activity of the
pump, thus blocking function (75). CPA is not as potent of a blocker as is thapsigargin
(75).
2,5-di (tert-butyl)l,4-benzohydroquinone (tBuBHQ)
2,5-di (tert-butyl)l,4-benzohydroquinone (tBuBHQ) is a synthetically made phenolic
compound, originally thought to be important for its antioxidant properties (161). It was
observed that tBuBHQ demonstrated a potent block of SERCA function as well as ATP
hydrolysis, the mechanism is not well understood (75).
RyR
In order to understand the RyR characteristics and function, pharmacological modulation
of [Ca2+]i is necessary. The following drugs are commonly used as pharmacological tools
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in studying the RyR. These modulators work by either stimulating or inhibiting Ca2+
release from the RyR (Figure 1.3).
Caffeine
Caffeine is an alkaloid that is found in plants. It is believed to selectively activate the
RyR channels by increasing the channels open probability without changing the channels
conductance properties (127; 128; 130). This increases the channels sensitivity to Ca2+,
which leads to the activation of the CICR process.
Ryanodine
Ryanodine is an alkaloid found in shrubs and trees of the genus Ryania (75). At
submicromolar concentrations, ryanodine increases RyR channel activity, and at
micromolar concentrations inhibits channel activity (75). It is still unclear whether or not
ryanodine modifies conductance by allosterically stabilizing the channel in a closed
formation, or actually interfering with the flow of ions through the pore of the channel
(135)
Procaine
Procaine is a derivative of cocaine (75). It was synthesized to utilize the anesthetic and
vasoconstrictive properties of cocaine, while avoiding its hallucinogenic and euphoric
affects (75). Unlike some of the other RyR channel blockers it does not affect channel
open time or ion conductance. In contrast, procaine lengthens the duration of the
channels closed state (75).
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Ruthenium red
Ruthenium red is a water-soluble dye that is generated from the reaction of RuC^ and
NH3 in solution (75). Ruthenium red selectively blocks RyR channels, but also has some
non-selective affects as in blocking voltage-gated Ca2+ channels (75).
Dantrolene
Dantrolene is a skeletal muscle relaxant that is used to treat human malignant
hyperthermia (62). Dantrolene’s antagonistic affects are more selective for RyRl, and
less selective for the other isoforms of the RyR channels (57; 62; 72; 167). The
mechanism of action is still not fully understood and it is not known whether dantrolene
exhibits a direct or indirect inhibition of the ryanodine receptor.
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Ryanodine receptor regulation in the
endoplasmic reticulum
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Caffeine
cADP
Ryanodine
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Figure 1.3. Modulation of the RyRs. Endogenous modulators of the RyR receptors play a
key role in the CICR process. Intracellular calcium can directly modulate the CICR
process once threshold intracellular calcium levels have been reached, and when bound to
calmodulin activates nitric oxide synthase. The activation of this enzyme leads to the
production of another modulator, cyclic adenosine diphosphate ribose(cADPr), through
the nitric oxide (NO), guanylate cyclase, cyclic guanosine monophoshate (cGMP),
cGMP-dependent protein kinase-1 (PKGi), cADPr pathway which can stimulate CICR.
Calmodulin can also inhibit the CICR process by binding free intracellular calcium,
preventing threshold calcium levels from being reached. Phosphorylation of the RyRs is
another important aspect of their modulation, increasing open probability of the channel.
All of these mechanisms in conjunction with one another contribute to the modulation of
the CICR process. Pharmacological modulators of RyRs includes: caffeine, exogenous
cADP and ryanodine.
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Pathology of ER/SR calcium release dysfunction
Congestive heart failure (CHF)
Calcium mishandling has been shown to play a crucial role in the development of
congestive heart failure(8; 15; 61; 168; 169). A lot of studies have reported the
involvement of RyR2 phosphorylation and dephosporylation in the development of this
disease. In fact, an enhanced calcium leak has been proposed to be the cause of this
pathogenesis (8). It has been reported that in normal ventricular cells that have been
stimulated with a p-adrenergic agonist, the RyR2 undergoes phosphorylation Normally
when FKBP is bound to RyR2, the channel is maintained in a closed state. PKA
phosphorylation of RyR2 results in the opening of the channel. One group hypothesizes
that in heart failure there is a hyper- adrenergic state, which leads to the activation of
PKA resulting in hyperphosphorylation of the RyR2. This hyperphosphorylation results
in the dissociation of FKBPs which will cause enhanced calcium leak (93). However this
remains controversial.
Malignant hyperthermia (MH)
This disease is a genetic disease caused by mutation in the RyRl gene (8; 15). Studies in
pigs show that this mutation leads to a hypersensitivity to calcium, resulting in an
94-

increase in CICR, and a decrease in Ca dependent deactivation. Rapid utilization of
ATP by SR calcium pumps and transporters trying to maintain calcium homeostasis leads
to an increase in heat generation (8; 15; 62; 69; 85). Certain anesthetics can also cause
muscle rigidity and an increase in body temperature, and if this increased rise in
temperature is not controlled by dantrolene (blocks RyRl), death will result (6; 72).
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Catecholaminergic polymorphic ventricular tachycardia (CPVT)
Mutations in RyR2 have been shown to be associated with catecholaminergic
polymorphic ventricular tachycardia (8; 50; 88). CPVT is a malignant, rare exerciserelated tachycardia. It usually occurs during intense exercise, and can result in sudden
cardiac death. One explaination of the mechanism is that a mutated RyR2 leads to an
increase in Ca2+ leak, overloads the Na+/Ca2+ exchanger which normally generates an
inward current as it extrudes Ca2+. This overload results in proximal tachycardia and
arrhythmias. Another is that phosphorylation of the mutated RyR2 leads to increased
Ca2+ leakage similar to that in malignant hyperthermia. This leads to hypersensitivity to
Ca2+ and decreased abilty to inactivate the channel.
Central core disease (CCD)
The mechanisms for this disease remains elusive, however there has been some
speculation on the cause of this disease. CCD disease is a result of RyRl mutations (8;
15; 100). Clinical symptoms usually exhibit muscle weakness, hypotonia, and motor
deficiencies. Type 1 skeletal muscle fibers are usually affected and are usually lacking
the central mitochondria and their oxidative enzymes. The reason for the lack of central
mitochondria is unknown. Like malignant hyperthermia, this disease causes and
excessive Ca2+ leak by an unknown mechanism. It may be possible that the lack of
central mitochondria may lead to decreased Ca2+ buffering capacity leading to this
pathology.
Brain disorders and neurodegenerative diseases
Changes in intracellular calcium homeostasis have been associated with the pathogenesis
of Alzheimer’s disease (AD) (70; 96; 97; 108). RyRs have been shown to be expressed in

19

abundance in brain regions that are shown to accumulate plaque. Also Querfurth et al has
demonstrated that the RyR-regulated pools have been shown to accelerate amyloid beta
production(122). Another group has reported that increased RyR levels were detected in
brain sections of Alzheimer’s patients, suggesting that the increased expression of the
receptors are involved in the development of this disease (70). Age in conjunction with
calcium dysregulation has also been implicated in Huntington’s disease, Parkinson’s
disease, and stroke (96; 97; 154).
Sympathetic neurons and SCG
Cervical ganglia
There are three cervical sympathetic ganglia which have three parts: 1) the superior
cervical ganglion; 2 ) the middle cervical ganglion; and 3) the cervicothoracic ganglion.
The superior ganglion has been shown to innervate the viscera of the head; the middle
and cervicothoracic ganglion innervate the viscera of the neck, thorax and upper limb.
Thoraxic and paravertebaral ganglia
The thoraxic sympathetic ganglia, innervates the trunk region, and the lumbar and sacral
sympathetic ganglia innervate the pelvic floor and lower limb. The paravertebral ganglia
is responsible for sympathetic innervation to blood vessels in muscle and skin, arrector
pili muscles attached to hairs, and sweat glands.
SCG innervation and their physiological roles
All organs and tissues have nervous innervation to connect the central nervous
system to the tissue. Alterations in the function or neuronal synaptic transmission of these
neuronal bridges may impact the function of that organ or may also affect other normal
bodily functions. The SCG has been suggested to be a peripheral neuroendocrine center
(24; 25). It innervates the pineal gland, thyroid and parathyroid gland, eye, cephalic
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blood vessels, chorotid plexus, carotid body, salivary gland, salivary glands, parotid
gland, thymus, tongue, cervical lymph nodes, eustachian tubes, ophthalmic artery, the
brain and other tissues, structures and organs (Table 1.1) (23-25; 27; 71; 76; 77; 94; 95;
103; 109; 123; 125; 132; 134; 153; 157; 159; 160; 162; 163).
The physiological roles of the SCG innervation to specific structures were
assessed in many studies. It has been demonstrated that upon stimulation of the CNS,
SCG terminals in the heart release NE that binds adrenergic receptors causing
strengthening of the heart contractions (162). Altered innervation of sympathetics has
been implicated in heart disease (28). Other studies by Chou et al showed that
denervation of the SCG resulted in altered choroidal blood flow (29). It has also been
demonstrated that the sympathetics, including the SCG plays are role in CSF formation
by influencing the function of the carotid plexus (86; 87). Another study by Chou et al
also demonstrated that the ophthalmic artery is innervated by the SCG and showed to
play a role in regulating the blood flow to the optic nerve (30). The data from these
studies suggest that innervation by the SCG is critical for cardiovascular function, and
cerebral blood flow. Therefore, the absence of this innervation can possibly lead to
increased risk of heart disease and hemorrhagic stroke.
Studies have reported that the SCG neurons tend to innervate organs that have
some secretory function (reviewed in (5). Earlier studies showed that removal of SCG
resulted in neuroendocrine changes including alteration in pituitary function (25), water
balance, and photoperiodic control of reproduction in several animals due to SCG
denervation to the pineal (133). In other studies, a decrease in LH and FSH were
observed as well as thyroid stimulating hormone and growth hormone release after SCG
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removal (22). There has also been suggested that there are associations between the SCG
and hypothalamus as a result of decreased NE uptake in rats that had the SCG removed
(reviewed in (25; 125)).
There have been numerous reports on altered immune functions after disruption
of SCG innervation to certain structures (94; 123; 157). Many studies are pointing to the
important role in the nervous system in immune function. The sympathetics have been
shown to innervate the cervical lymph nodes and the thymus, both which are involved in
the immune response (123). In addition, innervation of the lymphoid structures was
shown to play an important role in inflammation. Ramaswamy et al demonstrated that
disruption of SCG innervation resulted in reduced pulmonary inflammation after
attempting to stimulate a massive immune response (123). It was concluded that the SCG
can modulate the inflammation response. Studies have shown that the removal of the
SCG resulted in decreased infiltration of white blood cells into the lungs after attempting
to stimulate an inflammatory response (94). Neutrophils of rats with removed thymus
demonstrated a reduced chemotactic response and was unresponsive to
lipopolysaccharides stimulation (94). Another study also confirmed the involvement of
SCG in neutrophil function modulation in addition to macrophage responses (94).
Removal of the SCG also resulted in reduced mast cell mediated tumor necrosis factor
alpha-dependent cytotoxicity, solidifying its importance in immune function (14). It is
evident that disruption of SCG function will potentially compromise immune
responsiveness.
It is clear from the studies that have been performed, and the vast amount of
scientific evidence in literature, that the SCG plays an important multi-faceted role in the
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maintenance and proper function of many different organs and systems. For example,
cardiovascular health, cerebral blood flow, immune responsiveness, and reproductive
health are all reliant on proper SCG function.
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Table 1.1. Innervation of the SCG and consequences of altered
SCG function

SCG innervates:
Lacrimal glands

Removal or impaired SCG function
results in:

Thymus

Heart disease

Salivary glands

Impaired immune response
and function

Parotid gland

Altered carotid blood flow

Eye

Localized hypertension

Pineal gland

Retinal degeneration

Cerebrovasculature

Thickening of eye basement
membrane (compromises
retinal capillaries)

Eustachian tubes
Tongue

Altered function of the
hypothalamus (via pineal)

Thyroid/parathyroid
Cervical lymph nodes

Altered anterior pituitary
function (via pineal)

Heart (important in “fight
or flight” response)

Inability to reproduce
Increased CSF production
Altered calcium homeostasis
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Superior cervical ganglia (SCG) regulation on cerebral blood flow/pressure and the
role of SCG hypertension and stroke
Rising systolic blood pressure in both F344Rats and in humans increases the risk of stroke by
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the disruption of blood vessels (170). Thus, the risk
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Figure 1.4. Anatomy of the
superior cervical ganglia

brain barrier disruption (4; 20; 21; 63; 64). Thus,
any changes in adrenergic nerve function with
advancing age can

decrease their protective

function. This topic is emerging as an important area in biomedical research (68; 144).
The animal model that we use is the Fischer-344 rat. This model is a well-established
model of aging with relevance to humans (170).
The effect of altered cerebral blood pressure: hemorrhagic stroke
Hemorrhagic stroke has been one of the major clinical issues that affect the morbidity,
mortality and health care costs of our population today (1; 78). About 72% of the people
who suffer a stroke are 65 years of age and older. It is the third leading cause of death
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behind heart disease and cancer. The most important factor responsible for increased risk
of stroke with increasing age is hypertension. Among its many harmful effects high
blood pressure puts unnecessary stress on blood vessel walls which can cause the blood
vessels to thicken and deteriorate, eventually leading to a stroke. The aging process may
also accelerate several common forms of heart disease which can also lead to stroke.
Regulation of intracellular calcium (mechanisms) and its regulation with age
Aging in neurons
Our laboratory focuses on elucidating the functional changes in Ca2+ regulation that
occur during advancing age in vascular adrenergic nerves (117; 119; 142). As adrenergic
nerves play an important role in regulating cerebral blood flow especially in cases of
hypertension, we believe that elucidating these mechanisms may have clinical
significance in the future.
By measuring norepinephrine (NE) release, our early work demonstrated that
advancing age alters the function of adrenergic nerves (17; 18; 40; 41). These studies
suggested that adrenergic nerve endings become more reliant on mitochondrial Ca2+
uptake to control NE release (146). Other studies have suggested that there is an agerelated decline in the function of [Ca2+]i buffering mechanisms in some central neuronal
models (38; 102; 129). Thus, we investigated the impact of age on the effect of a
synthetic [Ca2+]i chelator to inhibit stimulation-evoked NE release. The chelator was
more effective at reducing stimulation-evoked NE release in arteries from old as
compared to young animals (145). In addition, we found that the effect of the SERCA
antagonists, thapsigargin or cyclopiazonic acid, to increase stimulation-evoked NE
release declined with age (147). Taken together these data suggested that an age-related
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decline in some [Ca2+]i buffering systems may cause the previously observed increased
reliance on mitochondria to control NE release (146).
Despite the complexity of the calcium buffering systems, our ongoing research has
made strides in determining how aging affects their function. By using Fura-2 to directly
measure [Ca2+]i in isolated SCG, we have shown that there is an increased reliance on
mitochondria and plasmalemma Ca2+-ATPases (PMCAs) to control high K+-evoked
[Ca2+]i transients with advancing age (17; 117; 118). We have shown that SERCA
function in SCG cells declines with age (116-118; 147). Despite an age-related decline in
SERCA function, these sympathetic nerves rely on compensatory mechanisms to
continue normal function (116; 117).
We have now expanded our studies to include the consequences of altered SERCA
function in terms of CICR signaling, and how this decline affects the refilling of ER
stores ((106; 107; 150). In addition, NO modulates CICR in neurons via the
NO/guanylate cyclase/cGMP-dependent PKGj/cADPr signaling pathway (33; 79; 83). In
our studies we have shown that NO released from nNOS- containing neurons augments
the function of adrenergic neurons (17; 98; 99). This may be a vital signaling pathway
whereby the impact of age on Ca2+ signaling in adrenergic neurons can be successfully
studied.
Ca2+ homeostasis and aging
A general age-related decline in the regulation of Ca2+ has been suggested to be a
cause of some pathology and cell death (Porter et. al. 1997). Even though there may be a
decline in regulatory function, we cannot rule out possible compensatory feedback
mechanisms that can work to maintain homeostatic [Ca2+]i levels, therefore maintaining
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neuronal function (58; 80; 84; 106; 119; 156). It is imperative to understand how [Ca2+]i
is regulated under normal conditions. This understanding may give us insights into what
may be occurring in pathological situations, such as stroke and hypertension.
It is thought that alterations in [Ca2+]i regulation may be a key player in
neurodegenerative diseases (110; 155). There is evidence that Ca 2+ influx in central
neurons increases with age (74; 105; 112; 114). Recent studies on CNS neurons have
shown that age-related increases in Ca2+ influx through Ca2+ channels may be
compensated by increased buffering (58; 106). In understanding the interplay between
buffering mechanisms to control [Ca2+]i, it seems logical that if an age-related change in
function of one buffering system occurs, a corresponding compensatory response by
other buffering systems may also occur (116; 117). For example, the ability of
calmodulin to activate plasma membrane Ca2+-ATPases (PMCA's) declines with age
(56). However, in rat basal forebrain neurons, mitochondria play an increased role in
buffering access [Ca2+]i (107). Thus, increased mitochondrial buffering can compensate
for an age-related decline in PMCA function.
SERCA function like PMCA function has also been shown to decline with age in
other excitable cells; however the mechanism for the observed age-related decline in
SERCA buffering remains elusive. Although SERCA-mediated 45Ca2+ uptake in skeletal
muscle and myocardium appears to decline with age, SERCA protein levels remain stable
(54; 165). This may suggest that changes are occurring posttranslationally, such as
decreased SERCA phosphorylation.

Decreased SERCA phosphorylation would not

affect protein levels may possibly lead to a decreased buffering capacity.
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Hypothesis and significance
In this study, we examined how aging alters the dynamics of CICR and how declined
refilling of the calcium stores by SERCA pumps may change in isolated SCG cells from
6, 12, 20, and/or 24 month-old Fischer-344 rats. Studies on the effects of aging on
intracellular calcium regulation in SCG may have implications in the decrease of
neuronal plasticity and loss of axons and dendrites during aging. The disruption of their
connection and function may in return affect their innervation and function to their organ
targets resulting in altered function of their target organs.

Thus our governing

hypothesis is: aging can alter the mechanisms of intracellular calcium refilling
(rapid and spontaneous) and release in rat superior cervical ganglia.
The specific aims for the proposed research are:
1) To measure rapid and spontaneous refilling of caffeine-sensitive ER,
intracellular calcium stores in Fura-2 loaded SCG cells, and to determine if
there are any changes with age. Rationale. For rapid refilling, we have shown
that there is an age-related decline in high K+-evoked [Ca2+]i which suggests that
influx of Ca2+ through voltage gated Ca2+ channels may decline with age.
However, high K+ evoked [Ca2+]i are consistent between successive applications
of high K+. Caffeine-evoked [Ca2+]i also decline with age. However, there is a
further age-related decline in the release of Ca2+ with successive applications of
caffeine. These data suggest that the ability to sustain Ca2+ release may decline
with age. For spontaneous refilling we have demonstrated that advancing age
results in a significant slowing of the rate of refilling of ER Ca2+ stores in SCG
cells following caffeine-evoked depletion of [Ca2+]i stores.
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2) To identify the major isoform(s) of the RyR in the rat SCG and to quantify
the age-related changes in the genetic and protein expression levels of the
major isoforms. Rationale. Preliminary studies have shown that SERCA
function declines with age which may affect the level of [Ca2+]i that is necessary
to cause Ca2+ release via the ryanodine channel pending further stimulation. By
using molecular techniques, we can detect changes in the message levels for the
ryanodine channel, and also detect channel density by western analysis or ELISA.
3) To measure the levels of selective endogenous agonists and/or modulators of
the ryanodine channel. Rationale. The ryanodine channel is modulated by many
mechanisms, including phosphorylation, and by the NO guanylate cyclase/cGMPdependent PKGi/cADPr pathway which modulates the endogenous agonist of the
channel, cADPr.

By measuring nNOS levels with the ELISA technique, and

phosphorylation state of the channels, we may gain some insight on how
modulation of these channels may change with age.
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A. Abstract
Intracellular calcium ([Ca2+]i) release from SER stores plays an important role in cell
signaling. These stores are rapidly refilled via influx through voltage gated calcium
channels or spontaneously via store-operated calcium channels (SOCC), and subsequent
pumping by smooth endoplasmic reticulum Ca2+ -ATPases (SERCA). We measured
[Ca2+]i transients in isolated Fura-2 loaded superior cervical ganglion (SCG) cells from 6,
12, 20 and 24 month-old F-344 rats. For rapid refilling, [Ca2+]i transients were elicited
by a 5 sec exposure to K+ (Si), caffeine to release Ca2+ from SER stores (S2), K+ to refill
SER Ca2+ stores (S3), and caffeine (S4). The % difference between the peak and rate of
rise of the first and second caffeine-evoked [Ca2+]i transient significantly declined over
the age range of 12-24 months. To estimate spontaneous refilling, cells were depolarized
for 5 sec with 68 mM K+ (control), followed by a 10 sec exposure to 10 mM caffeine
"conditioning stimulus" to deplete [Ca2+]i stores. Caffeine was then rapidly applied for 5
sec at defined intervals from 60 to 300 sec. Integrated caffeine-evoked [Ca2+]i transients
were measured and plotted as a percentage of the K+ response vs. time. The derivative of
the refilling time curves significantly declined over the age range from 12-24 months.
Overall, these data suggest that the ability of SCG cells to sustain release of [Ca2+]i,
following rapid or spontaneous refilling declines with advancing age. In addition, as
sympathetic neurons arising from the SCG serve to protect the cerbrovasculature from
hyperemia in the face of elevated blood pressure, these data have implications as to
protective function of these neurons during the normal aging process.
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Key words: Store operated calcium channels, aging and calcium release, aging and
refilling of neuronal calcium stores, aging and function of superior cervical ganglia.
B. Introduction
A prominent factor for increased risk of stroke during aging is rising systolic blood
pressure (1, 24). Adrenergic nerves arising from the superior cervical ganglia (SCG)
serve to dampen increased cerebral blood flow in response to hypertension or increased
intracranial pressure and reduces the risk of blood brain barrier disruption (3, 6, 7, 12,
18). Thus, age-related changes in adrenergic nerve function is emerging as an important
area in the physiology of aging (20,41).
The function of neurons depends in part on the release of calcium from the smooth
endoplasmic reticulum (SER) in response to an elevation in intracellular calcium
([Ca2+]i) mediated by voltage-gated Ca2+ channels (46-48). This process has been termed
calcium induced calcium release (CICR) and is relevant in processes such as release of
neurotransmitters and hormones (14, 31, 38, 47).
To sustain calcium release during neuronal activity requires refilling of the SER
calcium through calcium influx and subsequent uptake into the SER via smooth
endoplasmic reticulum calcium ATPase (SERCA) pumps (22, 37, 49). Thus, buffering of
[Ca2+]i transients and refilling [Ca2+]i stores by SERCA suggest that calcium release and
[Ca2+]i buffering are intimately related processes. In SCG and sensory neurons, SER Ca2+
stores can be rapidly refilled by activation of voltage gated calcium channels with high
K+ or they can spontaneously refill within 3-10 min following depletion with caffeine via
activation of store operated calcium channels (SOCC) (2, 10, 11, 36, 37, 47).
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Aging in all creatures is inexorable and the "why" of aging has been suggested to be a
combination of developmental changes, genetic defects, environmental influences and an
inborn aging process (8, 16, 17, 39, 42). However, these studies render little explanation
in terms of "how" normal aging alters function of critical organ and neuronal systems or
the vulnerability of particular physiological processes to advancing age. We have shown
that there is an age-related decline in SERCA function with a subsequent increased
reliance on mitochondria and plasmalemma Ca2+-ATPases (PMCA) to control high K+evoked [Ca2+]i transients with advancing age (4, 32, 34,44). Overall these data suggest
that despite an age-related decline in the function of SERCA cells may adapt to this loss
by increased function of remaining [Ca2+]i buffering mechanisms. Consistent with our
studies in SCO cells others have shown that the function of SERCA declines with age in
skeletal and heart muscle cells (13, 50). Thus, in peripheral excitable cells a subtle
decline in overall SERCA function may be a common feature of the aging process.
Given that SERCA function declines with age in the SCG we studied how aging may
alter the refilling and release of Ca2+ from the SER. We tested two hypotheses in this
study as illustrated in (Figure 2.1). The first hypothesis is that an age-related decline in
SERCA mediated Ca2+ uptake alters rapid depolarization induced refilling of Ca2+ into
the SER following caffeine-evoked depletion of SER Ca2+ stores. The second hypothesis
is that an age-related decline in SERCA mediated Ca2+uptake alters the spontaneous
refilling of SER Ca2+ stores following caffeine-evoked depletion.
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Hypothesis 2: An age-related decline in
SERCA-mediated Ca2+ uptake alters
spontaneous refilling after caffeine
depletion.
SERCA-mediated Ca2+ uptake

Hypothesis 1: An age-related decline
in SERCA-mediated Ca2+ uptake
alters
voltage-dependent
rapid
refilling after caffeine depletion.

Measured Variable

Caffeine-evoked depletion

Fig. 2.1. Model illustrating overall experimental design of this study. The measured
variable is relative cytosolic calcium concentration in response to various protocols used
within the study. The overall governing hypothesis is that an age-related decline in
SERCA function alters the SER calcium levels and their refilling following depletion.
Abbreviations: Smooth endoplasmic reticulum (SER). Smooth endoplasmic reticulum
calcium ATP-ase (SERCA). Voltage gated calcium channels (VOCC). Store operated
calcium channels (SOCC).
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C. Methods

C.l. Experimental animals
Male Fischer-344 (F-344) rats aged 6 mo (young adult), 12 mo (mature adult), 20
mo (old) and 24 mo (senescent) were obtained from NIH-NIA breeding colony (Harlan
Sprague-Dawley Incorporated, Indianapolis, IN, USA). The age-range designation comes
from other studies showing the median life span in F-344 rats is approx 24 months
(26).The animals were allowed to eat and drink at will and were maintained on a 12 hr
light/dark cycle under controlled temperature (72-77 °F). All procedures used in this
study were approved by the Institutional Animal Care and Use Committee (IACUC) at
Loma Linda University and the approved guidelines were adhered to throughout the
study.

C.2. Superior cervical ganglion preparation
Rats were anaesthetized with CO2 (45 sec) followed by decapitation. The
dissection of the superior cervical ganglia and preparation of isolated cells has been
described previously (34). Briefly SCO were dissected from the carotid artery bifurcation
and placed in cold Tyrode's solution which contained 150 mM NaCl, 4 mM KC1, 2 mM
CaCU 2 mM MgCL, 10 mM A-2-hydroxyethylpiperazine-A'-2-ethanesulphonic acid
(HEPES), and 10 mM glucose. The ganglia were then acutely dissociated in 5 ml of
Earle's balanced salt solution (BBSS) containing: trypsin (6000 U/ml), collagenase D (1
mg/ml), DNAse-1 type IV (0.1 mg/ml), HEPES (20 mM), glucose (10 mM), NaHCOs
(10 mM) and adjusted to pH 7.4 with NaOH (1M). After incubation in a shaking water
bath for 45 min at 34 °C, the digestion reaction was stopped by the addition of 5 ml of
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modified Hank's balanced salt solution (HBSS) with 10% fetal calf serum, 1.3 mM
CaCb, 5 mM HEPES and adjusted to pH 7.4 with NaOH (1M). Dissociated cells were
centrifuged at 600 rpm for 5 min and re-suspended in 5 ml of fresh HBSS. Cells were
centrifuged again at 600 rpm for 5 min and dispersed in 0.5 ml of HBSS with 10% fetal
calf serum, 5 mM HEPES adjusted to pH 7.4 with NaOH (1M) onto Cell-Tak (BD
Bioscience, Bedford, MA,) coated glass cover slips, (3.5 /xg/cm2). Cover slips were
modified by attaching a 2-cm Teflon ring to the surface with Sylgard adhesive (Dow
Coming, Inc. MI). Dissociated cells on the cover-slips were incubated for 12-14 hrs at
room temperature to allow cells to attach to the Cell-Tak protein coat before they were
used in the experiments.

C.3. Measurement of intracellular calcium

SCG cells were loaded with 10 /xM fura-2 acetoxymethylester (fura-2/AM) for 20
min at room temperature, then washed with low K+ tyrodes buffer containing: 138 mM
NaCl, 2 mM CaCl2, 1 mM MgCl2, 5 mM KC1, 10 mM HEPES, and 10 mM glucose,
adjusted to pH 7.4 with NaOH (1M). Incubation was continued for an additional 20 min
to allow intracellular esterases to convert the fura-2/AM dye into the free acid form (40).
A potential problem with loading procedures is that there may be an age-related
difference in the amount of Fura-2 taken up by the SCG cells or a difference in the
activity of non-specific esterase’s that convert Fura-2/AM to the free salt. To assess this
possibility, the intensity of the fluorescence signal at 510 nM when the dye is activated at
380 nM is proportional to the amount of loaded dye (30). In this study we monitored the
510 nM emission fluorescence signal when fura-2 is excited at 380 nm (Fsgo) in resting
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SCG cells in each age group. The F380 was not significantly different in SCG cells from
6-24 month-old animals. The specific values for F380 following loading were, 160.04 ±
5.6, 169.80 ± 5.0, 164.57 ± 11, 169.90 ± 7.0 in SCG cells from 6, 12, 20 and 24 monthold animals respectively. These data are consistent with our previous studies showing that
the F380 is does not change with age suggesting that dye loading is equivalent in SCG
cells from each age group (32, 33).
Cover slips were mounted into a superfusion chamber, which was attached to the
stage of a Nikon inverted microscope (Nikon Instruments, Tokyo, Japan). The
microscope was attached to a Universal Imaging System running MetaFluor version 6.2
(Universal Imaging Corporation, a subsidiary of Molecular Devices, West Chester, PA,
USA). The perfusion system allowed the chamber volume (~250/xl) to be exchanged at
the rate of 500 /tL (i.e. 2 times per second). A xenon lamp illuminated the fura-2 probe,
and fluorescence was excited alternately at wavelengths 340 and 380 nm by a Lamda
DG-4 (Sutter Instruments, Novato, CA, USA) hyper switch. The fura-2 emission
fluorescence was measured at 510 nm and recorded by a Photometric Cool Snap 12-bit
digital camera (Roper Scientific, AZ, USA). Adjusting the microscope stage to a point
with no cells in the field of view and capturing a background image before the start of the
experiment corrected for background light levels. Prior to fura-2/AM loading, cellular
autofluorescence was examined in SCG cells. Autofluorescence was found to be
undetectable by our imaging system and did not significantly alter our [Ca2+]i
measurements. During the experiment, 340 and 380 fluorometric signal were collected,
corrected for background fluorescence, calcium concentration calculated and the data
logged to an exel file at a rate of -300 msec. During dye loading and data collection,
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ambient light levels were minimized and SCG cells were only illuminated during data
acquisition to minimize bleaching and potential photo damage of the dye.

Intracellular calcium was estimated by both in vitro and in vivo calibration
methods. The in vitro method was performed using a calcium calibration kit (Molecular
Probes, Eugene, OR, USA) with known [Ca2+] ranging from 0 to 40 /xM. Each prepared
calcium solution was loaded with 4 jliM fura-2 pentapotassium salt. A droplet of each
[Ca2+] was placed onto a glass slide and the fluorescent intensities from 340 and 380
excitation were measured and a curve of 340/380 ratio (R) versus [Ca2+] was plotted. The
in vivo method was performed on SCG cells by decreasing extracellular calcium
concentration to 0 mM and fluorescence from 380 (Fmin), and 340/380 ratio (Rmin) was
recorded for 1 min. The extracellular medium was then replaced with 10 mM [Ca2+] with
ionomycin (1 pM) and depolarized with high potassium (68 mM). Values were then
recorded for 1 min to obtain Fmax and Rmax. The values for Fmjn, Rmm, Fmsix and Rmax were
remarkably similar between the in vitro and in vivo methods. Our in vitro calibration for
Kd is comparable with in vivo values in neuronal cells (28, 31) Furthermore, we applied
the same Kd for both young and old SCG neurons, since previous reports have shown no
significant change in fura-2 Kd values for young and old neurons(28). Since our in vitro
method correlated well with in vivo measurements, the values obtained from the in vitro
calibration were used to convert the experimental fluorescent intensity ratios (R) to [Ca2+]
over the physiological range of [Ca2+]i by iterative fit to the equation: [Ca2+]i = Kd [R Rmin]/Rmax - R] Sf. Rmjn is the 340/380 ratio at zero [Ca2+] and R max is the 340/380 ratio at
40 pM [Ca2+]. The value of Ad is the dissociation constant of fura-2, while Sf is a
correction factor relating the ratio FmiJFmax, which is the emission intensity at 380 nm
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when fura-2 is in the free (Fmin, 0 jxM [Ca2+]) or bound (F,max* 40 pM [Ca2+]) form (15).
For this report we used multiple calibrations and the [Ca2+]i was estimated using
averaged in vitro values for Sf (11.3), Fmin (0.39), R max (2.5) and Kd (270 nM).

C.4. Protocol 1: Measurement of K+-evoked (fast) Refilling of [Ca2+]i stores.

Figure 2.2A shows representative data in a single SCG cell from a 6 month-old
animal demonstrating the response to sequential additions of high K+ and caffeine to
release and refill
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Fig. 2.2. (A) Representative data of protocol 1 demonstrating caffeine-evoked release of [Ca2+]i
from SER stores and fast K+-evoked refilling of [Ca2+]i stores in a single Fura-2 loaded SCG cell
from a 6-month animal. An [Ca2+]i transient (Si) was evoked by 5 sec exposure to 68 mM K+
followed by 2 min equilibration. A second [Ca2+]i transient (S2) was evoked by 5 sec exposure to
10 mM caffeine to release calcium from [Ca2+]i stores followed by 2 min equilibration. The third
[Ca2+]i transient (S3) was evoked by 5 sec exposure to 68 mM K+ to refill [Ca2+]i stores followed
by two min equilibration. A final [Ca2+]i transient (S4) was evoked by 5 sec exposure to 10 mM
caffeine followed by 2 min equilibration. (B) Data derived from a single Fura-2 loaded SCG cell
from a 6 month animal demonstrating selective caffeine evoked Ca2+ release from [Ca2+]i stores.
An [Ca2+]i transient was evoked by 5 sec exposure to buffer containing 68 mM K+ and 2 mM
extracellular Ca2+ followed by 2 min equilibration. A second [Ca2+]i transient was evoked by 5
sec exposure to buffer containing 10 mM caffeine and zero extracellular Ca2+ (3 mM EGTA)
followed by 2 min equilibration. Next the cell was exposed for 5 sec to buffer containing 68 mM
K+ and zero extracellular Ca2+ (3 mM EGTA) followed by two min equilibration. A final [Ca2+]i
transient was evoked by 5 sec exposure to buffer containing 68 mM K+ and 2 mM extracellular
Ca2+.
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SER [Ca2+]i stores. Cells were exposed for 5 sec to 68 mM K+ (Si) to insure
uniform loading of SER [Ca2+]i stores (27). Next cells were exposed for 5 sec to 10 mM
supermaximal, caffeine, (S2), to release calcium from SER [Ca2+]i stores. Next a 5 sec
exposure to high K+ to rapidly refill the SER [Ca2+]i stores (S3) and caffeine to once
again release calcium from the SER (S4). These data show that we can reproducibly
generate [Ca2+]i transients with different treatments and that in young cells high K+ is
able to refill the SER Ca2+ stores. Figure 2.2B illustrates that caffeine selectively releases
calcium from SER calcium stores in SCG cells. Note that caffeine still evokes an [Ca2+]i
transient in the absence of extracellular calcium. These data are consistent with other
studies demonstrating that caffeine selectively evokes release of calcium from SER
[Ca2+]i stores in SCG cells (11).
2,

C.5. Protocol 2: Measurement of Spontaneous Refilling of [Ca ]i stores

Figure 2.3 illustrates the protocol in a single SCG cell used to measure how aging
may alter the spontaneous refilling of [Ca2+]i stores following caffeine-evoked depletion.
This protocol was derived from a previous study in acutely dissociated dorsal root
ganglion cells (45). Previous studies have shown that the initial responses of isolated
neurons to caffeine can be quite variable suggesting variability in the loading of [Ca2+]i
stores (2, 27). This variability to caffeine can be markedly reduced by initially
depolarizing the cells to insure equal loading of [Ca2+]i stores. Thus, the cells were
exposed for 5 sec to high K+ (Si) as a normalization control (data not shown) and to
insure a more uniform loading of [Ca2+]i stores (2, 27). Next caffeine sensitive SER
[Ca2+]i stores were depleted by a 10 sec exposure to 10 mM caffeine (S2) called the
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“conditioning response” (data not shown). Following the conditioning response, the SER
calcium stores were allowed to spontaneously refill and cells were briefly exposed to 10
mM caffeine for 5 sec at the intervals indicated until the maximal response to caffeine
following the “conditioning response” was obtained.
C.6. Data analysis
Calcium transients were analyzed using Origin 6.1 software in all age groups. In
protocol 1 peak [Ca2+]]i was determined by subtracting basal [Ca2+]i from the maximum
K+ or caffeine-evoked [Ca2+]i transients. Rate of rise of [Ca2+]i was determined by linear
fit (r = 0.99 ± .07) from basal [Ca2+]i to the maximum K+ or caffeine-evoked [Ca2+]i.
Rate of recovery of [Ca2+]i transients was determined using a first order exponential fit (r
= 0.99 ± .06 ). In protocol 2 caffeine-evoked [Ca2+]i transients following the conditioning
response for were analyzed by taking the total area under the curve and normalization to
the area under the curve of the K+ control. Thus, data is expressed as integrated caffeineevoked [Ca2+]i as a percentage of the K+ control. These data were plotted vs time after the
conditioning response to estimate the spontaneous refilling of [Ca2+]i stores as shown in
Figure 2.8A. The rate of spontaneous refilling following caffeine-evoked release of
calcium from [Ca2+]i stores was estimated by taking the derivative of the curves in
Figure 2.8A using Origin 6.1 and is expressed in Figure 2.8B.
C.7. Statistics
The impact of age on all measured parameters was determined using ANOVA and
Fischer PLSD test. All data in each age group were analyzed for heterogeneity of
variance using the Cochrans test. If the variances were significantly different then values
were log transformed and statistical tests were repeated (51).
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D. Results
D.l. Properties of high [fC and caffeine-evoked [Ca2+]i transients
Using the protocol in figure 2.2A we calculated the peak and rate of rise of the
first and second high K+-evoked [Ca2+]i transients in each age group as shown in Figure
2.4. There is a clear age related effect on the peak and rate of rise of the first and second
high K+-evoked [Ca2+]i transients. These parameters increased in SCG cells from 6-12
month-old animals and then progressively declined from 12-24 months. Despite the
decline in these parameters from 12-24 months the consistency of the dynamic response
between the first and second high K+-evoked [Ca2+]i transients appears to be maintained
with advancing age. Again using the protocol in figure 2.2A we calculated the peak and
rate of rise of the first and second caffeine-evoked [Ca2+]i transients in each age group as
shown in Figure 2.5. In a similar fashion to high K+, these parameters increased in SCG
cells from 6-12 month-old animals and significantly declined from 12-24 months. In
contrast to the high K+-evoked [Ca2+]i transients, the peak and rate of rise of caffeineevoked [Ca2+]i transients appears decline from the first and second exposure to caffeine
in SCG cells from 12-24 month-old animals.
To clarify how advancing age may alter the consistency of the peak and rate of
rise of high K+ and caffeine-evoked [Ca2+]i transients, we analyzed the percentage
difference between the first and second high K+ or caffeine-evoked [Ca2+]i transients.
When the data were analyzed in this manner, a clearer pattern emerges as shown in
figure 2.6. There is no significant age-related decline in the percentage difference in the
peak and rate of rise of the first and second high K+-evoked [Ca2+]i transients. In contrast
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to high K+, there is a significant age-related decline in the percentage difference in the
peak and rate of rise of the first and second caffeine-evoked [Ca2+]i transient.
D.2. Spontaneous refilling of [Ca2+]i stores following caffeine-evoked depletion
To enhance the rigor of our study on the impact of age on spontaneous refilling of
[Ca2+]i stores (Figure 2.3) we performed a series of validation controls as shown in
figure 2.7. These controls were done to demonstrate that spontaneous refilling of [Ca2+]i
stores following caffeine-evoked release occurred independently of voltage-gated
calcium channels and appears to be dependent on the activation of SOCC and SERCA as
shown in previous studies (2, 45,47). In figure 2.7A we demonstrate that [Ca2+]i stores
in resting SCG cells will refill in the presence of the L and N-type voltage gated calcium
channel antagonists nifedipine and co-conotoxin respectively, following caffeine-evoked
depletion of [Ca2+]i stores. Note that in the presence of the voltage-gated calcium channel
antagonists, cells still exhibit robust caffeine-evoked release of [Ca2+]i. In figure 2.7B
we show the efficacy of the L and N-type channel calcium antagonists on high K+-evoked
peak [Ca2+]i transients. Note that both nifedipine and co-conotoxin block approximately
97% of the K+-evoked Ca2+ response suggesting that L and N-type channel subtypes
predominate in the SCG as previously shown (23). Figure 2.7C demonstrates the
activation of SOCC channels following caffeine-evoked depletion of and blockade of the
SERCA mediated refilling of [Ca2+]i stores. Note that under these conditions [Ca2+]i
begins to rise reflecting the opening of SOCC as shown in previous studies (2, 47).
However, in the continued presence of the SERCA blocker TRAPS, caffeine no longer
elicits a response. These data suggest that in addition to calcium influx via SOCC,
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SERCA are also necessary for spontaneous refilling of [Ca ]i stores in resting SCG cells.
An interesting observation is that the time for activation of SOCC in our preparation
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Fig. 2.3. Example of protocol 2 demonstrating the spontaneous refilling of SER calcium
stores following caffeine-evoked emptying in a single SCG cell. Cells were exposed for 5
sec to 68 mM K+ and then for 10 sec to 10 mM caffeine representing the control and
conditioning response respectively (data not shown). At the time points indicated
following the conditioning response, 10 mM caffeine was applied for 5 sec until the
maximum response to caffeine was achieved.
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Fig. 2.7. Validation controls to determine that SOCC channels and SERCA mediate spontaneous
refilling of SER calcium stores following caffeine-evoked release. (A) SER calcium stores refill
in the presence of calcium channel blockers, nifedipine and co-contoxin. Cells were exposed for 5
sec to high K+ buffer (Si) followed by a 10 sec exposure to a buffer containing 10 mM caffeine to
release [Ca2+]i stores (S2). Next the cells were continually exposed to a buffer containing 10 /iM
nifedipine and 1 /tM co-conotoxin to block L and N-type calcium channels respectively. As
indicated the cells were exposed to again exposed for 5 sec to a buffer containing 10 mM
caffeine. Data represent the average for 5 cells from a 6 month-old animal. (B) L and N-type
channel antagonists, nifedipine and co-conotoxin block K+-evoked [Ca2+]i transients in SCO cells.
Cells were exposed for 5 sec to high K+ buffer (control). Next cells were exposed for 5 sec to
high K+ buffer containing 10 fiM nifedipine and then for 5 sec to high K+ buffer containing 10
jaM nifedipine and 1 /cM co-conotoxin. Data represent the mean ± S.E for 6 cells from a 6 monthold animal. (C) Activation of SOCC channels occur following the caffeine-evoked depletion of
SER calcium stores and blockade of SERCA with thapsigargin (THAPS). Cells were exposed for
5 sec to high K+ (Si) and then to 10 mM caffeine for 10 sec (S2). Next cells were continually
exposed to a buffer containing the SERCA antagonist THAPS, 1 /cM. At the times indicated the
cells were exposed for 5 sec to a buffer containing 10 mM caffeine. Data represent the average of
4 cells from a 6 month-old animal. (D) Activation of SOCC channels is blocked with La3+
following caffeine-evoked depletion of SER. Cells were exposed for 5 sec to a buffer containing
high K+ (Si). Next cells were exposed for 10 sec to a buffer containing 10 mM caffeine (S2).
Following S2 cells were continually exposed to a buffer containing THAPS (1 /tM) and La3+ (100
[jlM). At the times indicated cells were exposed for 5 sec to a buffer containing 10 mM caffeine.
Data represent the average for 5 cells from a 6 month-old animal.
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appears slow relative to activation of SOCC in other cell models (19). Figure 2.7D
demonstrates that La3+ blocks the activation of SOCC following caffeine-evoked
depletion of [Ca2+]i and blockade of SERCA by THAPS. Under these conditions [Ca2+]i
no longer rises after depletion of [Ca2+]i stores and subsequent responses of SCG cells to
caffeine are abolished. Overall these data demonstrate that spontaneous refilling of
[Ca2+]i stores in resting SCG cells following the release of [Ca2+]i appears to be mediated
by both SOCC and SERCA activity (2, 47).
Figure 2.8 demonstrates that advancing age alters the spontaneous refilling of SER
Ca2+ stores via SOCC and SERCA activity following caffeine-evoked depletion of
[Ca2+]i stores. After caffeine evoked depletion (S2), the cells were exposed for 5 sec to
caffeine at the time intervals shown in figure 2.3. The data in figure 2.8A show that
there is a significant age-related decline in the response to caffeine at each time point
after the conditioning response. However, at the 240 sec time interval, there is no longer
any significant difference in the response to caffeine in any age group. To estimate the
rate of spontaneous refilling of [Ca2+]i stores following caffeine-evoked depletion we
calculated the derivative of the curves in figure 2.8A, and plotted these values as a
function of age (Figure 2.8B). The derivatives were found to be significantly lower in
SCG cells from 12, 20, and 24 month-old animals as compared to 6-months (Figure
2.8B).
D.3. Measurement of Basal [Ca2+]i and rate of recovery of high K+ and caffeine-evoked
[Ca2+]i transients
Table 2.1 shows the impact of age on basal [Ca2+]i following successive exposures to
high K+ and caffeine using the protocol in figure 2A. Under all treatment conditions
basal [Ca2+]i significantly increases in SCG cells from 6-12 month-old animals and then
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significantly declines from 12-24 months. Table 2.2 shows the impact of age on the
recovery rate constant following exposure to high K+ or caffeine as shown in the protocol
in figure 2.2A. There is no significant age-related change in the magnitude of the
recovery rate constants with any of the successive exposures to high K+ or caffeine.
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Table 2.1: Basal [Ca2+]i significantly declines from 12-24 months following each
treatment in protocol 1. Data represent the mean ± S.E. n = 21-42 cells from each age
group. P<0.05.
6 Month
12 Month
20 Month
24 Month
1st KCI
164.7 ±9.8 224.2 ±12 133.7 ±12.5 79.8 ±12
1st Caffeine 135.6 ±8.5
183.1 ±9
120.5 ±12
73.3 ±10
182.1 ±12 249.6 ±11
2nd KCI
162.3 ±12
99.8 ±13
2nd Caffeine 158.6 ±9.2 209.1 ±7.5
138 ±10
94.5 ±11

Table 2.2. Rate of recovery of [Ca2+]i transients with each treatment in protocol 1 in
isolated SCG cells from 6-24 month-old animals. Rate of recovery was calculated by
obtaining the first order time constant (Tc) using Origin 6.1. The reciprocal of Tc yields
the rate constant. N= 21-42 cells from 12-20 animals.

6 Month
1st KCI
0.16 ±0.01
1st Caffeine
0.14 ±0.01
2nd KCI
0.15 ±0.01
2nd Caffeine
0.14 ±0.01

12 Month
0.19 ±0.01
0.18 ±0.02
0.18 ±0.01
0.15 ±0.01

79

20 Month
0.16 ±0.01
0.13 ±0.01
0.16 ±0.01
0.12 ±0.01

24 Month
0.17 ±0.01
0.15 ±0.01
0.16 ±0.01
0.13 ±0.01

E. Discussion
The most important and straightforward findings in this study is that release of
calcium from [Ca2+]i stores and high K+-evoked and spontaneous refilling of these stores
declines with advancing age in SCG cells. The magnitude and shape of stimulationevoked increases in [Ca2+]i are modulated by both influx of and release of calcium in
neurons (25,46-48). Sustaining the release of calcium from intracellular stores during
ongoing activity requires the refilling of these stores following the release. Overall, the
data in this study suggest that the ability to sustain release of calcium from intracellular
stores declines with age and may have implications as to the function of sympathetic
neurons during the aging process. As refilling of [Ca2+]i stores is dependent on both
influx and uptake into the SER via SERCA the decline in refilling may reflect and age
related decline in the function of both mechanisms. Indeed, we have shown that SERCA
function declines with age in sympathetic neurons (32, 33, 43, 44). Thus, at least one
mechanism that may account for the decline in refilling of [Ca2+]i stores is an age-related
decline in the function of SERCA pumps. As adrenergic nerves from the SCG serve to
protect the CNS from blood brain barrier disruption (3, 5, 7, 12, 18), these data suggest
that the ability of the SCG to sustain its protective function may possibly be altered with
advancing age.
E.l.Aging and fast refilling of [Ca2+]i stores
The data reported in this study (Fig. 2.2B) as well as published data suggest that
selective release of calcium from intracellular stores in dorsal root ganglion (DRG) and
SCG cells can be accomplished with caffeine (11, 25, 35, 47). In addition, these stores are
rapidly refilled by depolarization of the neurons following exposure to caffeine (11, 25,
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35, 47). Thus, we utilized a protocol to determine if advancing age alters repeated
caffeine-evoked release of [Ca2+]i after high K+-evoked refilling (Fig 2.2A). There was
no age-related difference in the [Ca2+]i dynamics between the first and second high K+evoked [Ca2+]i transient (Fig. 2.6A,B)- Thus, although the dynamics of K+-evoked
[Ca2+]i transients decline with age, they remain constant within each age group. In
contrast to K+-evoked [Ca2+]i transients, advancing age caused a significant reduction in
the [Ca2+]i dynamics between the first and second caffeine exposure within the oldest age
groups (Fig. 2.6C,D). There are numerous studies demonstrating the impact of age on
depolarization-evoked [Ca2+]i transients (4, 33, 34, 44, 49). However, to our knowledge
this is the first study demonstrating that the ability of peripheral neurons to sustain the
release of calcium following rapid depolarization-evoked refilling, declines with age.
Interpretation of the overall age-related decline of K+-evoked [Ca2+]i transients is
complex (Fig. 2.4) as depolarization-evoked [Ca2+]i transients reflects both influx and
release of calcium (46). Using patch clamp methods coupled with measurement of [Ca2+]i
with fura-2, one study showed that stimulation-evoked calcium influx increases but the
measured [Ca2+]i by fura-2 declines with age (28). The measurement of K+-evoked
[Ca2+]i in this study does not directly distinguish between the contributions made to the
calcium signal by influx, and release of calcium from intracellular stores. Thus, it is
possible that at least one mechanism that may account for the decline in K+-evoked
[Ca2+]i dynamics is reduced release. However, these data do not rule out changes in
calcium influx mediated through voltage gated calcium channels.
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Fig. 2.4. (A, B) Peak [Ca2+]i evoked by the first and second exposure to high K+ in
isolated SCO cells from animals aged 6-24 months. (C,D) Rate of rise of [Ca2+]i evoked
by the first and second exposure to high K+ in isolated SCG cells from animals aged 6-24
months. These data were derived from the protocol shown in figure 2A. Peak [Ca2+]i was
measured by subtracting basal [Ca2+]i from the maximum K-i-evoked [Ca2+]i transient.
Rate of rise of [Ca2+]i from baseline to maximum was determined by linear fit using
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= significantly different
from three other age groups, P<0.05.
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E. 2 Aging and spontaneous refilling of [Ca2+]i stores
There are studies demonstrating that in SCG and DRG cells the [Ca2+]i stores can
spontaneously refill within 3-10 min following depletion with caffeine (11, 25,45,47).
This spontaneous refilling of [Ca2+]i stores requires two interdependent mechanisms.
These are the spontaneous influx of calcium through SOCC and subsequent pumping of
calcium into the SER via SERCA (2, 47). The function of SOCC channels can be
blocked with ions such as La3+ and SERCA function is blocked by TRAPS (2, 47). Since
we have previously shown that SERCA function declines with advancing age in isolated
SCG cells (32, 34, 44), we developed an experimental protocol to study the impact of age
on the spontaneous refilling of [Ca2+]i stores following caffeine-evoked depletion (Fig.
2.3). In order to validate that the spontaneous refilling of refilling of [Ca2+]i stores is
independent of VOCC and mediated by SOCC and SERCA activity we performed a
series of validation experiments (Fig. 2.7). These control data suggest that in isolated
resting SCG cells spontaneous refilling of [Ca2+]i stores appears to be mediated by influx
of calcium via SOCC and subsequent uptake into the SER via SERCA pumps. These data
are consistent with previous studies demonstrating that spontaneous refilling of [Ca2+]i
store is mediated by SOCC and SERCA function (2, 2, 47).
To our knowledge this is the first study to demonstrate that spontaneous refilling
of [Ca2+]i stores slows with age in isolated SCG cells (Fig. 2.8). Interestingly, it appears
that SCG cells from senescent animals will eventually refill to similar levels if given an
appropriate amount of time. Thus, SCG cells from healthy senescent animals maintain
some ability to release and spontaneously refill [Ca2+]i stores, implying that some level of
function of sympathetic neurons is maintained with age. Using various antagonists of
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SERCA we have shown that SERCA function declines in both SCG cells and
sympathetic nerve endings (32, 34, 43, 44). We propose that at least one mechanism that
may account for a decline in spontaneous refilling of [Ca2+]i stores is reduced SERCA
function. However, these data do not rule out age-related changes in SOCC function. We
are currently developing protocols to study how aging may alter SOCC function.
EJ.Aging and basal [Ca2+]i levels and rate of recovery of[Ca2+]i
Surprisingly we found that basal [Ca2+]i levels rose from 6-12 months and then
steadily declined with age (Table 2.1). The increase in basal [Ca2+]i from 6-12 months
may reflect late maturational changes. In our previous studies using only two age-groups
we found no significant difference in basal [Ca2+]i levels in SCG cells from 6 and 20
month-old animals (32, 34). Comparison of the current data with our previous studies
succinctly demonstrates the necessity of using more than two age groups in aging studies.
Using multiple age groups appears to be essential as the range from maturity to
senescence provides a clearer overview of how advancing age affects the parameters of
interest (9). Since we have shown that SERCA function declines with age in SCG cells
one might predict higher resting levels of [Ca2+]i. Indeed our data stand in contrast to
age-related increases in basal [Ca2+]i in DRG neurons (21). These data may suggest that
the aging process may not have uniform effects on all neuronal models. Since SERCA
function depends on both the level of cytosolic calcium and modulation by other factors
such as phosphorylation (50), reduced levels of cytosolic calcium may possibly
contribute to lower loading levels of [Ca2+]i stores.
Depolarization-evoked [Ca2+]i transients depend on influx and release of [Ca2+]i
(46, 47), and caffeine-evoked [Ca2+]i transients reflect calcium released from [Ca2+]i
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stores. Thus, lower loading levels of [Ca2+]i stores may possibly contribute to an agerelated decline in both high K+ and caffeine-evoked release of [Ca2+]i observed in these
studies (Fig. 2.4,2.5). In future studies we will use calcium indicators such as furaptra to
determine the impact of age on the levels of SER [Ca2+]i stores similar to studies
accomplished in smooth muscle cells (29).
Since SERCA function declines with age in SCG cells (32, 44) it is remarkable
that there is no age-related change rate of recovery of high K+- or caffeine-evoked [Ca2+]i
transients. However, rate of recovery of high [Ca2+]i transients in SCG cells is complex
as we have shown that SERCA, mitochondrial calcium uptake and PMCA all contribute
to the rate of recovery of high [Ca2+]i transients in SCG cells (4, 32, 34, 44). In addition,
we have shown that the age-related decline in SERCA function is accompanied by an
apparent increased reliance on mitochondrial calcium uptake and PMCA function (4, 32,
34). Taken together our current and past studies suggest that in the face of an age-related
decline in SERCA function, the rate of recovery is maintained by increased activity of
other calcium uptake and extrusion systems. These data suggest that with advancing age
buffering systems do not necessarily “fall apart” as a decline in one system may be
compensated for by increased function of another system. Thus old SCG cells appear to
have inherent adaptive responses to maintain some vitality in the face of age related
declines the function of particular calcium regulatory mechanisms.
In conclusion, the data presented in this study suggest that with advancing age
there is an age-related decline in the ability of SCG cells to sustain release of calcium
from [Ca2+]i stores. These data may have implications for the function of sympathetic
autonomic neurons as animals undergo the normal aging process.
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Fig. 2.5. (A,B) Peak [Ca2+]i evoked by the first and second exposure to 10 mM caffeine
in isolated SCO cells from animals aged 6-24 months. (C,D) Rate of rise of [Ca2+]i
evoked by the first and second exposure to 10 mM caffeine in isolated SCO cells from
animals aged 6-24 months. These data were derived from the protocol shown in figure
2.2A. Peak [Ca2+]i was measured by subtracting basal [Ca2+]i from the maximum
caffeine-evoked [Ca2+]i transient. Rate of rise of [Ca2+]i from baseline to maximum was
determined by linear fit using Origin 6.1. Data represent the mean ± S.E. n = 21-42 cells
from each age group. ** = significantly different from two other age groups, P<0.05.
= significantly different from three other age groups, P<0.05.
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A. ABSTRACT
Sympathetic nerves arising from the superior cervical ganglion (SCO) protect the
cerebrovasculature during periods of acute hypertension and may play a role in
homeostasis of target organs. The functions of these nerves depend on calcium release
triggered by activation of ryanodine receptor (RyR) channels. The function of RyR
channels is in part dependent on genetic expression and regulation by numerous proteins
modulators such as neuronal nitric oxide synthase (nNOS) neurons also found in the
SCO. We have shown that release of calcium in SCG cells is altered during late
maturation and advancing age. However, the underlying molecular mechanisms that may
in part account for these data are elusive. Therefore we used molecular techniques to test
the hypothesis that advancing age alters the pattern of genetic expression and/or protein
levels of RyRs and their modulation by nNOS in the SCG in F-344 rats aged 6, 12 and 24
months. Surprisingly, ryrl expression was undetectable in all age groups and ryr2 and
ryr3 are the predominantly transcribed isoforms in the adult rat SCG. mRNA and
protein levels for RyR2 isoform did not change with advancing age. However, ryr3
mRNA levels increased from 6 to 12 months and declined from 12 to 24 months.
Similarly, RyR3 receptor protein levels also increased from 6 to 12 months and declined
from 12 to 24 months. Because nNOS and the phosphorylation of the RyRs have been
shown to modulate the function of RyRs, total phosphorylation and nNOS protein levels
were analyzed in all age groups. Phosphorylation levels of the RyRs were similar in all
age groups. However, nNOS protein levels increased from 6 months to 12 months
followed by a decline from 12 months to 24 months. These data suggest that advancing
age selectively impacts the genetic expression and protein levels of RyR3 as well as
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modulatory nNOS protein levels. In addition, these data may part provide some insight
into the possible changes in the function of RyRs that may occur with the normal aging
process.
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B. INTRODUCTION
Clinical studies show that risk of stroke increases with age, and the single most
important factor is rising systolic blood pressure (1, 14, 32, 69). Thus, a more
comprehensive understanding of aging and modulation of the cerebrovasculature is
necessary. Systolic blood pressure rises in both F344-Rats and in humans suggesting that
the cerebrovasculature is subjected to increased pressure and risk of hyperemia and stroke
(14, 68). The SCG provides sympathetic innervation to the cerebrovasculature, and
dampen increased cerebral blood flow in response to hypertension or increased
intracranial pressures (19). Therefore, sympathetic nerves arising from the SCG reduce
the risk of blood brain barrier disruption and are becoming an increasingly important area
in biomedical research (6, 14, 25, 55).
In addition to the importance of the SCG in the cerebrovasculature, the SCG
innervates and impacts the function of many organs including the heart (29, 41, 61, 65,
66), the eye (23, 53, 62, 64), and secretory glands, such as the pineal gland (30, 31)
thyroid/parathyroid and salivary glands (7, 9, 10, 26, 49). It has also been suggested that
the SCG and other sympathetic neurons function as a peripheral neuroendocrine center
(8, 9) serving as the communication bridge between the central nervous system and the
endocrine system (9, 52). The SCG has also been shown to play an important role in the
immune response (36, 48, 63).
The function of peripheral sympathetic and sensory neurons has been shown to be
dependent on release of calcium from intracellular stores in response to stimulationevoked increases in intracellular calcium ([Ca2+]i) (34,44, 56-58). This process is known
as calcium induced calcium release (CICR) and occurs through the activation of
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ryanodine receptor channels. The function of RyR channels depends in part on density
and their regulation. The regulation of the function of RyRs is complex and overall this
regulation serves to modulate the sensitivity of RyR’s to cellular Ca2+ levels. These
modulators include FKBP proteins, which serve to activate or inhibit channel state
depending on its binding status, and activators such as phosphorylation and intracellular
molecules including cADP-ribose (cADPr) (24, 35,45). In the case of cADPr these levels
are modulated by nitric oxide (NO) released from nNOS containing neurons. Indeed our
studies and others have shown that the SCO and the cerebrovasculature is innervated by
nNOS neurons, which function to modulate stimulation-evoked norepinephrine release
(12, 33, 37, 38).

To maintain the CICR process the [Ca2+]i stores must be refilled. Refilling
depends on the amplification of [Ca2+]i, which occurs through such channels as voltage
gated calcium channels, and store operated calcium channels, and by pumping Ca2+ back
into the stores by smooth endoplasmic reticulum calcium ATP-ases (SERCA). We have
previously demonstrated that there is an age related decline in SERCA-mediated Ca2+
uptake in the SCO (47). This decline in SERCA function influences caffeine-evoked
release of Ca2+ and both rapid depolarization-induced and spontaneous refilling of SER
Ca2+ stores after depletion (60). These data suggested that advancing age alters the
capacity of SCG cells to release Ca2+ from SER stores and that the levels of the SER Ca 2+
may also decline with age, which may possibly alter the function of the SCG.
The three isoforms of the ryanodine receptor family are RyRl (found in skeletal
muscle), RyR2 (found in cardiac muscle), and RyR3 (found in neurons, and other tissue
types) have been shown to be responsible for CICR (45). As discussed above, these
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receptors are important in the function of sympathetic neurons and sympathetic neurons
arising from the SCG may serve to protect the CNS from rupture of blood vessels at
higher systemic pressures. As maturation and aging are normal and inevitable processes it
is necessary to study underlying mechanisms that may account for how animals develop
and age. Thus, molecular characterization of the RyRs and/or selective modulators may
provide information on calcium release during the aging process. The expression, overall
phosphorylation, and modulation of RyR’s by nNOS with late maturation or advancing
age has not previously been studied in the rat SCG model. As the function of multiple
subtypes of RyR’s are important to the overall function of numerous excitable cells the
genetic expression and protein levels of RyR channels in models that have not been
previously studied are warranted. Using molecular techniques of RT-PCR and ELISA
analysis we tested the hypothesis that the genetic and protein expression of the
predominant RyR isoform(s) in adult rat SCG, along with selective modulators, are
altered during late maturation and advancing age in F-344 rats aged 6, 12 and 24 months.
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C. MATERIALS AND METHODS
C.l. Experimental animals
Male Fischer 344 (F-344) rats, aged 6 mo (young adult), 12 mo (mature adult), and 24
mo (senescent), were obtained from National Institutes of Health-National Institute on
Aging breeding colony (Harlan Sprague-Dawley, Indianapolis, IN). The age range
designation comes from other studies showing the median life span in F-344 rats is '•24
months. The animals were allowed to eat and drink at will and were maintained on a
12:12-h light-dark cycle under controlled temperature (72-77°F). All procedures used in
this study were approved by the Institutional Animal Care and Use Committee at Loma
Linda University, and the approved guidelines were adhered to throughout the study.
C.2. SCG isolation and sample preparation
Rats were anesthetized with CO2 (45 s) followed by decapitation. Both carotid arteries
were dissected from each male F-344 rat. SCG were dissected from the carotid artery
bifurcation as previously described (60). Tissue was pulverized in liquid nitrogen into a
fine powder using a metal mortar and pestle, then placed in cold lysis buffer (8.77g NaCl,
7.88g Tris HCL, 3.29g EDTA, 5ml 0.5% Tween-20, and broad spectrum protease
inhibitors and sonicated until homogenous.
C.3. Isolation of SCG total RNA
Total RNA from 6, 12 and 24 month old animals were isolated using the Ambion
RiboPure RNA isolation kit (Ambion, Austin, TX) according to the manufacturer’s
recommendations. Briefly, the rat SCG was dissected out of the 6, 12 or 24 month old
animals and pulverized using liquid nitrogen. The pulverized tissue was then re
suspended in RNAwiz and the RNA was separated from SCG proteins by the addition of
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chloroform and centrifugation. The RNA was precipitated and treated with DNAse 1 to
eliminate genomic DNA. The integrity of the RNA was determined by assessing the
260/280 ratio. RNA samples with ratios between 1.8-2.0 indicate high purity of RNA
and samples yielding these values were used for all RT-PCR reactions.
C.4. Reverse-transcriptase PCR
The primers used for reverse transcription-PCR (RT-PCR) analysis were specific for the
ryrl, ryr2, ryr3 and GAPDH determined by using the NCBI blast database for Rattus
norvegicus (Table 1). RT-PCR reactions (50/xl) using RT-PCR reaction mix (Promega,
Madison, WI) were performed with samples containing RNA ranging from 10 ng to 1 pg
for optimization. To test for DNA contamination we performed negative controls, which
consisted of the same RT-PCR reaction mix contained in the biological samples minus
reverse transcriptase.
C.5. SDS-PAGE and Immunoblot analysis
This study utilized an ELISA assay along with selective antibodies to determine
relative RyR2, RyR3 levels and nNOS levels in SCG. Therefore, we first validated the
selectivity of our antibodies for these respective proteins using sodium dodecyl sulfate
polyacrylamide gel (SDS-PAGE) electrophoresis and Western blot analysis. We have
shown in our previous studies that the antibodies for nNOS are highly selective and yield
single bands (37).
Similarly for RyR2 and RyR3 levels we determined the selectivity of polyclonal
rabbit anti-rat antibodies for the respective RyR’s using a modified method [Figure 3.3,
(21)]. Briefly, SDS-PAGE was performed using a 4 to 12% Bis-Tris polyacrylamide gel
(NuPAGE Novex gels, Invitrogen, Carlsbad CA) in MOPS (morpholinepropanesulfonic
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acid)-SDS running buffer according to the manufacturer's instructions (Invitrogen,
Carlsbad, CA.). Samples were prepared [(65% sample containing 25 fig of total protein),
(25% 4xNuPAGE LDS sample buffer), (10% NuPAGE reducing agent)], heated at 72°C
for 10 min, and then electrophoresed at 200 V for 120 minutes in the XCell SureLock
Mini-Cell system using the Hi-Mark high molecular weight standards (Invitrogen,
Carlsbad, CA.). The separated proteins were then transferred to PVDF membrane
(Millipore, Bedford, MA). The blots were probed with ryanodine-specific antibodies
(Chemicon, Temecula CA). Immunoreactive proteins were detected by the procedure
described in the Western Lightning chemiluminescence reagent plus kit (Perkin-Elmer
Life Sciences. Boston, MA.). Selectivity of the RyR2 and RyR3 are further validated by
Chemicon using RyR2 and RyR3 positive and negative tissues and assurance of these
controls are provided by Chemicon. Thus, with information provided by Chemicon and
our independent analysis in this study suggest that the RyR2 and RyR3 selective
antibodies are reliable antibodies for quantification of these isoforms using ELISA assay.
C.6. ELISA
There are two issues with regards to Western analysis of RyRs. First, RyRs are greater
than 500 kDa and due to its high molecular weight may not transfer well. Secondly,
incomplete transfer will affect the accuracy of the quantitation of RyR protein levels.
Thus, ELISA assays were developed to measure their levels eliminating the need for
transfer of proteins from separation gels to blotting membranes (21). We used a modified
ELISA assay to measure RyR2 and RyR3 protein levels relative to GAPDH levels.
Similarly, we used the ELISA to measure nNOS levels relative to GAPDH. We first
performed a saturation curve to determine the optimal amount of protein to use in
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quantification of RyR’s and nNOS in rat SCG (Figure 3.6). The serial dilutions of total
proteins, ranging from 15.6ng-2/xg, were incubated in high binding 96-well plates
(Coming, Coming NY) for 16-24 hours at 4°C. The unbounded proteins were washed
away using PBS-T (138 mM NaCl, 2.7mM KC1, pH 7.4,0.1% Tween-20) and blocked
using 1% BSA for 1 hour at room temperature. The antigen-coated wells were washed
twice with PBS-T and then incubated with the RyR2, RyR3, GAPDH or nNOS
antibodies for 16 hours at 4°C. The antigen-coated plates were then washed three times
with PBS-T and incubated with the HRP-conjugated antibodies for 1 hour at 37°C. The
unbounded antibodies were washed away using PBS-T and then incubated with hydrogen
peroxide and 2,2’-Azino-di-(3-ethylbenz-thiazoline) Sulfonic Acid (ABTS) (Zymed,
Invitrogen, Carslbad, CA) for 15-20 minutes ABTS is oxidized to yield a green
chromophore and absorbance was measured at 405 nm using a microplate reader. The
optimal concentrations of protein to be used for experiments were assessed and
experiments were followed as described above. Negative controls were performed in the
absence of primary antibodies. GAPDH was also determined in each age group to serve
as a loading control. In addition, all colorimetric intensity values obtained for RyR’s were
normalized to GAPDH.
C.7. Phosphorylation analysis of the RyRs
The relative total RyRs present in adult rat SCG were analyzed for levels of
phosphorylation according to manufacturer’s protocol (Molecular Probes, Invitrogen,
Carslbad, CA). Briefly, 25 pg determined by Bradford assay (BioRad) of total SCG
protein from 6, 12 and 24 month old animals were subjected to SDS-PAGE for
separation. After 1 hour of electrophoresis, the PeppermintStick phosphoprotein
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molecular weight standard (Molecular Probes, Invitrogen, Carlsbad CA) was then loaded
on the gel and electrophoresed for an additional 1 hours. This standard served as a
positive phosphoprotein control. The gel was fixed, washed, stained with the Pro-Q
Diamond phosphoprotein stain and destained as described by manufacturer’s protocol.
The phosphoproteins were imaged using transillumination at 540 nm. The images were
documented and the proteins were then stained using SYPRO Ruby protein gel stain. The
total proteins were then documented and ratio of phosphoprotein stain signal to total
protein stain signal of the total RyRs were assessed. To ensure that the proper protein
band was being assessed, immunoblot analysis was performed using mouse anti-RyR
antibodies which detect all three isoforms (Sigma, St. Louis MO). As an additional
internal control to insure that the method accurately detected phosphorylated forms of the
ryanodine receptors, we prepared gels using two different amounts of total protein (12.5
jLtg and 25 /zg). There was an increase in intensity of phorsporylated ryanodine receptor
for the higher total protein, however, the ratio of total ryanodine protein to
phosphorylated ryanodine did not change.
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D. RESULTS
D.L Saturation curve for RT-PCR analysis and validation ofprimer specificity
Reverse-transcriptase PCR is a powerful tool and has commonly been used to
semi-quantitate mRNA levels. However, because PCR is an exponential process, if not
optimized correctly, PCR type detection can be problematic. To ensure that saturation of
the amplified products do not occur, primers for GAPDH, ryr2, and ryr3 were used to
establish a curve to determine the optimal concentration of total RNA concentrations to
use. Total RNA concentrations ranging from 10ng-120ng were used and amplified for 50
cycles. 60-75ng of total RNA showed to be ideal to use for quantitative purposes (data
not shown). The desired molecular weights were determined by electrophoresis of the
amplicons (Table 3.1). To ensure that the amplified products were the desired products
and not non-specific priming of the oligonucleotides, the amplified products were
sequenced by the UC Davis sequencing core facility and were shown to be either ryr2,
ryrS or GAPDH.
D.2. Identification of the major ryanodine receptor isoforms in rat and impact of age on
their expression
The predominant isoforms of the ryr in rat SCG has not previously been
demonstrated. To identify what ryr isoform transcript(s) are predominantly present in rat
SCG, RT-PCR performed on SCG DNase treated total RNA isolated from 6 month, 12
month and 24 month animals. Concentrations RNA up to 1 /xg, did not yield any
amplified fragment consistent with the ryrl (Fig. 3.1). Since ryrl was shown to be
present in the brain, we utilized RNA isolated from the cerebral cortex of a 6 month old
rat as a positive control to ensure that primer conditions were appropriate and primers
were
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Table 3.1. Primers used in this study

Primer Sequences
RyRl FWD
RyRl REV
RyR2 FWD
RyR2 REV
RyR3 FWD
RyR3 REV
GAPDH FWD
GAPDH REV

5’CCA GGG GAG GAT GAC ATA GAA GG 3’
5’GAG GGT CAG GTT TGC GCT CAT TG 3’
5’ACA CCC TCC GCC TCT ACT CT 3’
5’GGG TGA TGC TCT TTG TCT CC 3’
5’GAA CCG AGA TGT TGC TGT GTG 3’
5’GTC CTG CCC AGC AAA AAT G 3’
5’ACC ACA GTC CAT GCC ATC ACT 3’
5’AGT TGG GAT AGG GCC TCT CTT 3’
Amplicon Size

RrRl = 520bp
RyR2 = 245bp
RyR3 = 392bp
GAPDH= 540bp
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specific. The predicted size fragment was amplified from brain RNA, but not from the
SCG, confirming that proper primer conditions were used. ryr2 and ryr3 were transcribed
in rat SCG demonstrating that these two isoforms are the predominant ryr transcripts in
rat SCG cells (Figs 3.2). To ensure no contaminating DNA was present, the reaction was
also performed in the absence of reverse transcriptase (data not shown). No amplified
fragment was observed.
Semi-quantitative RT-PCR analysis of ryr2 normalized to GAPDH from the 6, 12
and 24 month showed no significant alteration in the ryr2 transcript with advancing age
(Fig 3.2). In contrast to ryr2, ryr3 normalized to GAPDH message significantly increased
in the 12 month in comparison to the 6 month, followed by a significant decline in 24
month-old animals.
D.3. Saturation curve analysis for ELISA, and validation of antibody specificity
Since RyRs are very high molecular weight proteins, quantification by standard
western blotting procedure can be very difficult due to incomplete transfer. Because of
these factors, ELISA assay was used to measure RyR levels as it is commonly used for
protein detection and quantification. To determine that the antibodies used in these
ELISA are specific for RyR2 and RyR3, SCG proteins were transferred onto a PVDF
membrane, blocked and then probed using RyR2 and RyR3 specific antibodies.
Immunoreactive bands larger than 500 kDa, consistent with the size of the ryanodine
receptors were detected (Fig. 3.3A). These data demonstrate that the antibodies are
selective for the ryanodine receptors 2 and 3, which were detected in the SCG samples.
To ensure saturation does not occur with the ELISA procedure, a serial dilution of the
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Figure 3.1. The ryrl transcript is not the predominant ryr isoform in adult SCG. 75 ng of
DNase treated total RNA isolated from rat SCG ganglia or rat brain was subjected to
reverse transcriptase-PCR (RT-PCR) using ryr7-specific oligonucleotides. RT-PCR
products were then subjected to gel electrophoresis and stained with ethidium bromide
and visualized by UV-excitation. No detectable amplified product consistent with the
predicted ryrl transcript was detected from rat SCG RNA. To ensure primer conditions
were optimized and specific, RNA from rat brain was used as a control.

Ill

A

C

o*V°*
245 bp

Ryr2

540 bp—►

GAPDH 540 bp

B

Ryr3

392 bp

GAPDH

D
2

2i

«
>

>

u
« x

0) Q.

cn <

So

5o
%2

si
= |
> Z

*
o

CL

0

★★

11D fLLi
6 Month

12 Month

24 Month

6 Month

12 Month

24 Month

Age

Age

Figure 3.2. Transcriptional profiling of ryr2 and ryr3 with advancing age. (A, C) 60 ng
of DNase treated total RNA isolated from rat SCG was subjected to RT-PCR using ryr2
or ryr3 specific oligonucleotides shown in Table 1. RT-PCR products were amplified
then subjected to gel electrophoresis and stained with ethidium bromide and visualized by
UV-excitation and optical density was measured. (B, D) Density analysis of the ryr
messages were normalized to the GAPDH transcript; (A, C). (A, B): There is no
detectable age-related alteration of ryr2 transcript in adult rat SCG. (C, D): The ryr3
message expression changes with age in rat SCG. Data represent the mean ± S.E. n = 3
replicates from 12 pooled ganglia from each age group, performed in two independent
experiments. Data were analyzed by ANOVA and Fischer-PLSD test. * = significantly
different from one other age group, P <0.02. ** = significantly different from two other
age groups, P<0.02.
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SCG sample ranging from 15.6 ng-2ug of total protein was used, in addition various
antibody dilutions ranging from 1:500-1:2000 were also used. These data demonstrate
500 ng of total SCG protein/well and a 1:500 dilution of both RyR2 and RyR3 were
optimal (Fig. 3.3B).
DA. Protein expression analysis of RyR2, RyR3 and nNOS by ELISA assay and
phosphorylation of total RyR’s with advancing age
ELISA quantification showed that RyR2 levels normalized to GAPDH showed no
significant differences with advancing age (Fig. 3.4A). In these studies GAPDH served
as a normalization control since there is no change in its levels over the age range 6, 12
and 24 months (Fig. 3.4A inset). In contrast to RyR2, levels of RyR3 normalized to
GAPDH, there was a significant increase in RyR3 levels in the 12 month old SCG in
comparison to the SCG of the 6 month old animals followed by a significant decrease in
the RyR3 levels at 24 months (Fig. 3.4B with inset GAPDH). In addition to changing
RyR expression levels, phosphorylation level of the total RyR was assessed. Ratio of
phosphostaining to total protein staining showed no significant alterations in the levels of
RyR phosphorylation with advancing age (Fig. 3.5). As an added control to insure
detection of phosphorylated RyR’s we used a phosphoprotein standard kit containing
ovalbumin phosphoprotein, which was postively phosphostained. In contrast the nonphosphophorylated protein controls bovine serum albumin and beta-glactosidase did not
stain with the phosphostain (data not shown). We assessed the protein levels of nNOS
normalized to GAPDH in the SCG over the age range from 6-24 month-old animals.
There was a significant increase in the proteins levels of nNOS 6 month to 12 month,
followed by a significant decline of nNOS protein levels in 24 month old animals (Fig.3.
6).
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Figure 3.3. Validation of RyR2 and RyR3 antibody specificity, and saturation curve
analysis for RyR2 and RyR3 ELISA. (A) 25 pg of total rat SCG protein were subjected to
SDS-PAGE, transferred to PVDF membrane and probed with RyR2 or RyR3 antibodies.
The ryanodine receptor antibodies immunoreacted with high molecular weight bands
approximately 550 kDa, demonstrating the selectivity of the antibodies for RyR2 and
RyR3. (B) SCG were isolated from 12 month old rats. ELISA plates were coated with
serially diluted SCG protein, concentrations ranging from 23.5 ng-2pg total protein.
Saturation curves determined that 500 ng of total SCG protein/well and a 1:500 dilution
of both RyR2 and RyR3 were optimal.
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Figure 3.4. Ryanodine receptor expression levels with advancing age. High binding
ELISA plates were coated with 500ng of rat SCG proteins from all age groups. The
RyR2, RyR3 and GAPDH (normalization controls, inset) proteins were probed with
rabbit RyR2, RyR3 or GAPDH-selective antibodies. H2O2 and ABTS serves as substrates
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complex. ABTS is oxidized to yield a green chromophore and absorbance was measured
at 405 nm. (A): Results demonstrate that RyR2 protein expression does not significantly
change with age. (B): RyR3 protein expression levels change with age. Bars represent
the mean ± S.E. and were analyzed by ANOVA and Fischer-PLSD test, **
significantly different from two other age groups, P < 0.03. n=3 experiments using 6
pooled ganglia per experiment.
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P < 0.03. n= 3 experiments with 6 pooled ganglia per experiment.
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E. DISCUSSION
We have previously demonstrated a decline in caffeine-evoked release of Ca2+
and a decline in the ability of the superior cervical ganglia cells to sustain release of
intracellular calcium with age (60). In the present study we attempted to illuminate some
of the possible molecular mechanisms underlying our previous functional studies. We
have molecularly identified and characterized the ryanodine receptors with advancing age
in this study. Surprisingly, we have found that the ryrl message is not predominantly
expressed in the rat SCO contrasting other studies demonstrating ryrl is present in
excitable cells including neurons (Reviews (17, 51). Thus, a novel conclusion from these
studies is that independent of late maturation and advancing age RyRl does not appear to
play role in mediating the release of calcium in the SCO. However, RyR2 and RyR3 are
the major receptor isoforms that regulate calcium release from RyR sensitive stores in the
SCG in all age groups. In addition, late maturation and advancing age from adult to
senescent animals only alters the ryr3 mRNA and RyR3 protein levels. Overall
phosphorylation of RyR2 and RyR3 did not change in any of the age groups, suggesting
that aging does not necessarily alter modulation of RyR’s via phosphorylation. However,
nNOS has been shown to play a role in modulation of RyR sensitivity to changes in
[Ca2+]i levels through modulation of cADPr levels (13, 27). Our data demonstrates the
presence of nNOS in the SCG and late maturation and senescent aging significantly
increase then decrease nNOS levels. Thus, overall the combination of age-related
changes in RyR3 levels, altered modulation by nNOS and our previous data suggesting
the SER calcium levels may decline with age (47, 60) may combine to significantly alter
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the function of RyR3 and possibly RyR2 in the SCG and alter the function of calcium
release mechanism.
D.l. Aging and genetic expression ryrl, 2 and 3
It has been demonstrated that the ryrl is predominantly expressed in skeletal
muscle, ryr2 is predominantly expressed in cardiac muscle and ryr3 is expressed in many
tissue types, but predominantly in brain and neurons [Reviewed in (17, 18, 35, 39, 45, 50,
51)]. Numerous studies have shown differential genetic expression of ryr 1,2 and 3
isoforms in various neuronal models (15, 28, 42, 43, 59). However, to our knowledge
this is the first report of on the genetic expression of ryrl, 2 and 3 in the SCG model. In
this study, transcriptional analysis of adult rat SCG demonstrated the transcription of both
ryr2 and ryrS, however, to our surprise no transcription of ryrl was detected in the SCG
using total RNA concentrations up to 1 microgram, yet it was detectable in substantial
quantity in our positive control, the cerebral cortex. This data does not necessarily
suggest that RyRl is not expressed in adult rat SCG, but suggests that it is not the major
isoform of the adult rat SCG and may be detected using higher concentrations of RNA.
Furthermore, these observations may vary among tissues of different developmental age.
It has been shown that during the embryonic stage of the mouse brain, ryrl expression
was the highest in the rostral cortical plate, ryrS expression was the highest in the caudal
cortical plate, and low levels of ryr2 were expressed in the diencephalon and brain stem.
However, after 7 days postnatal, ryr2 appeared to be the major isoform in many regions
of the brain (42). Indeed this observation has also been shown in during embryonic
development in the mouse cerebral cortex where the expression of ryr2 progressively
increases and becomes the predominant isoform, where the other isoforms remained

119

lower (15). This may also possibly occur in the embryonic and postnatal development of
the rat SCG and is a subject of ongoing investigation in our laboratory.
Transcriptional analysis of the ryanodine receptors in the SCG demonstrates that
ryr2 and ryr3 are the major ryr transcripts present in SCG and their gene products may be
responsible for calcium release from the SER stores. The ryr2 gene expression did not
change with age suggesting that ryr2 levels remain stable during late maturation and
senescent aging. However, mRNA coding for the ryr3 isoform increased from 6 to 12
months and then significantly declined from 12 to 24 months of age. To our knowledge
this study is the first to show that there appears to be a late maturational increase in the
ryr3 isoform with a subsequent decline with senescence. These results do not necessarily
differentiate between changes in genetic expression or altered stability of the mRNA in
the age groups. Thus, both possibilities may explain the results. Overall, the data suggest
that the contribution of ryr3 to the RyR3 protein levels and ultimately calcium signaling
in the SCG may change with age while the contributions provided by RyR2 levels remain
stable.
D.2. Aging and protein levels of RyR2, RyR3 and modulatory nNOS
Changes in genetic expression alone do not necessarily hold a complete
explanation for altered RyR protein levels or regulation of the RyR’s. Thus, we measured
RyR2 and RyR3 protein levels using an ELISA assay and normalized to the stable marker
GAPDH. Following a similar pattern mRNA RyR2 protein levels were not changed in
any age groups. The lack of a change in RyR2 protein levels in any age group suggests
that this isoform may remain stable and functional throughout the adult life span. On the
other hand the turnover rate of the RyR2 in neuronal cells was not evaluated, which may
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possibly affect protein function. Indeed protein turnover plays a role in recycling of
amino acids and ensures the destruction of proteins that have been damaged by cellular
processes or oxidation (54). In addition, numerous proteins turnover rates decline with
age (16). For example in muscular tissue, the turnover rate of the RyR was decreased by
25% in the aged rats in comparison to the younger rats (16). RyR turnover has not been
evaluated in SCG and may change with age. Any alterations in turnover rate may have an
impact on the RyR2 protein function such as increased oxidation and protein damage in
the SCG. In contrast to RyR2, RyR3 protein levels increased from 6 to 12 months and
then declined at 24 months. However, the decline at 24 months was not significantly
smaller than at 6 months. Thus, a straight-forward conclusion as to functional
consequences of this age-related decline is difficult to make. We have shown that
caffeine-evoked release of calcium declines with age (60). As caffeine-evoked calcium
release offers a measurement of the functional capacity of the RyR sensitive stores, it is
difficult to interpret a mechanism based on the alterations in RyR3 protein levels alone.
However, the function of the RyR’s also depends on SER calcium filling levels as well as
the modulation of the RyR’s. Indeed, we have shown that SERCA function declines in
the SCG (47) and that basal levels of [Ca2+]i also decline with age (60). Thus, filling
levels of the SER may also be compromised which may alter the functional capacity of
the release mechanism. In addition, protein levels do not necessarily fully correlate with
protein function as some may undergo post-translation modification and may require
accessory proteins and modulators to regulate their function. It has been reported that
RyR function can be influenced by several factors, including phosphorylation, binding
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proteins, calcium levels and nNOS which modulates cADPr levels and in turn modulates
RyR’s [Reviewed in (3, 11, 13, 20,40)].
To evaluate if there are changes in selected modulators of the channels, we
measured the levels of total phosphorylation. This type of assay provides a general probe
as to the relative phosphorylation levels of the RyR’s and was used to determine if further
investigation of specific phosphorylations RyR’s with antibodies was warranted. Total
phosphorylation of RyR channels was not altered with age. These data suggest that
changes in steady state phosphorylation and hence regulation by this mechanism is not
necessarily occurring. NO synthesized by nNOS has been shown to be implicated in
modulating calcium in neurons (13). It is involved in the production of nitric oxide and
can be directly regulated by calmodulin, a calcium binding protein. It is part of the signal
transduction pathway responsible for cADPr synthesis, which directly affects the activity
of the ryanodine receptors and modulates release of calcium from SER stores. In
addition, we have observed that the addition of nitric oxide donors increased caffeineinduced calcium release in SCG cells (unpublished data). Given the importance of nNOS
in the function of RyR’s we measured nNOS protein levels in the SCG. Our data
demonstrate that nNOS is indeed present in the SCG which is consistent with other
studies demonstrating that the SCG contains nNOS neurons in addition to adrenergic
neurons (12, 67). Our data demonstrated that with advancing age, nNOS protein
expression increases from 6 to 12 months and significantly declines from 12 to 24
months. In addition, as nNOS activity modulates cADPr levels, which in turn modulate
RyR activity it may reasonable to speculate that these data may possibly suggest that
cADPr levels may also decline with age. As there appear to only be two RyR’s
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contributing to calcium release in the SCG, overall, the age-related decline in RyR3,
coupled with a decline in nNOS levels may in part provide an explanation for the
decrease in RyR mediated calcium release with age noted in our previous study (60). We
hypothesize that an age-related reduction in RyR3 receptor levels and cADPr levels may
account in part for a decline in the function of RyR’s. We are currently determining if
advancing age alters cADPR levels in the SCG, which may shed light on activity of
nNOS during the aging process and regulation of RyR’s.
As previously noted the regulation of the RyR’s is very complex and there is not
necessarily a consensus on the mechanisms governing the regulation of RyR’s. In
addition to the regulatory mechanisms discussed above, we offer some speculative
discussion on other processes not evaluated in this study that may also affect the function
of the ryanodine receptors, for example, modulation by thiol oxidation (2, 22,46). It has
been reported that oxidizing conditions can affect the calcium sensitivity of the RyR2 and
the affinity of the RyR2 for calmodulin (22). The oxidation states and the ability of the
RyRs to be regulated by oxidation in the SCG cells has not been evaluated and may be
altered in aged SCG compared to younger SCG. In addition, we cannot rule out the
possibility that accumulating mutations may arise with natural aging. These mutations
may compromise the function of these receptors. It has been shown that the mitochondria
play an important role in calcium regulation from buffering of calcium to production of
ATP for promoting proper cellular processes to maintain homeostasis (4, 5). It has been
reported that defects and mutations of the mitochondrial DNA and genes accumulates
with the natural aging process and these mutations may influence calcium regulation in
the ER [Reviewed in (4)]. In addition, there is an increase in reactive oxygen species
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produced by the mitochondria with advancing age [ Reviewed in (4)], which may result
in increased DNA or protein damage in the SER. This increase in oxidative stress in the
aging brain and neurons may be due to the reported decrease in antioxidant enzyme
activities [Reviewed in (4) ].
In this study, we have identified the major ryanodine isoforms of the adult rat SCG and
molecularly characterized their expression levels and at least one protein modulator,
nNOS with advancing age. ryrl does not appear to be expressed in the adult SCG
suggesting that RyRl does not contribute to calcium release in the adult SCG. However,
RyR2 and RyR3 appear to be the major contributors to calcium release function in the
SCG. Advancing age only altered RyR3 levels but to a small extent. Thus, based on
results of this study and our previous work, the combination of a decline in RyR3,
reduced nNOS levels, reduced function of calcium pumps that fill SER calcium stores,
may possibly act in concert to alter modulation of RyR’s in the SCG and in part may
play a role in the age-related decline in intracellular calcium release in adult rat SCG.
Overall these data may have implications for the protective function that the SCG
provides to the cerebrovasculature in the face of age-related elevations in blood pressure.
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CHAPTER FOUR
FINAL DISCUSSION/CONCLUSION
The aging process does not always result in the dramatic deterioration in all
individuals, hence the coined phrase “aging gracefully”. However, there are those
individuals who appear to deteriorate rapidly, showing marked changes over the course
of their battle with time. The differences that make some people evade the effects of the
aging process, and the succumbing of others is not well understood. This study focuses
on the dynamics of intracellular calcium regulation and its role in autonomic nerve
function.
We have evaluated the effects of aging on the dynamics of intracellular calcium (both
refilling and release), and expression of the ryanodine channels in rat SCO. Studies on the
effects of aging on intracellular calcium regulation in the SCO may have implications in
decreased neuronal plasticity and loss of axons and dendrites during the aging process.
The disruption of their connections and function may in return affect innervation, and
function to their target organs resulting in organ pathology.

Thus, the central

hypothesis of this study is aeing can alter the mechanisms of intracellular calcium
refilling (rapid and spontaneous) and release in rat superior cervical ganglia.
Several questions were posed to address the central hypothesis (Figure 4.1)and are
addressed in the following specific aims:
1) To measure rapid and spontaneous refilling of caffeine-sensitive ER, intracellular
calcium stores in Fura-2 loaded SCG cells, and to determine if there are any
changes with age.
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Findings of this study
Clinical implications
The most important and straightforward findings in this study is that the release of
calcium from [Ca2+]i stores, and both rapid and spontaneous refilling of these stores
declines with advancing age in SCG cells. Sustaining the release of calcium from
intracellular stores during ongoing activity requires the refilling of these stores following
the release. Overall, the data in this study suggest that the ability to sustain release of
calcium from intracellular stores declines with age and may have implications as to the
function of sympathetic neurons during the aging process. Since refilling of [Ca2+]i stores
is dependent on both influx and uptake into the SER via SERCA, the decline in refilling
may reflect an age related decline in the function of both mechanisms. We have
demonstrated in previous studies that SERCA function declines with age in sympathetic
neurons (7; 24; 25; 29), and this may be at least one mechanism that could account for the
decline in refilling of [Ca2+]i stores with age. As adrenergic nerves from the SCG serve
to protect the CNS from blood brain barrier disruption (4; 5; 13; 15), these data suggest
that the ability of the SCG to sustain its protective function may possibly be altered with
advancing age.
Aging and fast refilling of [Ca2+]i stores in aging SCG
In this study, there was no age-related difference in the [Ca2+]i dynamics between
the first and second high K+-evoked [Ca2+]i transients (Chapter. 2.6A,B). Although the
dynamics of K+-evoked [Ca2+]i transients decline with age, they remain constant within
each age group. In contrast to K+-evoked [Ca2+]i transients, advancing age caused a
significant reduction in the [Ca2+]i dynamics between the first and second caffeine
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exposure within the oldest age groups (Chapter. 2.6C,D), which directly implicates
changes in the dynamics of release. There are numerous studies demonstrating the impact
of age on depolarization-evoked [Ca2+]i transients (3; 25; 26; 29; 34). However, to our
knowledge this is the first study demonstrating that the ability of peripheral neurons to
sustain release of calcium following rapid depolarization-evoked refilling, declines with
age.
Interpretation of the overall age-related decline of K+-evoked [Ca2+]i transients is
complex (Chapter. 2.4) as depolarization-evoked [Ca2+]i transients reflects both influx
and release of calcium (30). It does not distinguish between the contributions made to the
calcium signal by influx, and release of calcium from intracellular stores. However, it is
possible that at least one mechanism that may account for the decline in K+-evoked
[Ca2+]i dynamics is reduced release.
Aging and spontaneous refilling of[Ca2+]i stores in rat SCG
In this part of the study, we developed an experimental protocol to study the
impact of age on the spontaneous refilling of [Ca2+]i stores following caffeine-evoked
depletion (Chapter. 2.3). In order to validate that the spontaneous refilling of [Ca2+]i
stores is independent of VOCC and predominantly mediated by SOCC and SERCA
activity, we performed a series of validation experiments (Chapter. 2.7). These control
data suggest that in isolated resting SCG cells spontaneous refilling of [Ca2+]i stores
appears to be mediated by influx of calcium via SOCC and subsequent uptake into the
SER via SERCA pumps. These data are consistent with other studies demonstrating that
spontaneous refilling of [Ca2+]i stores is mediated by SOCC and SERCA function (1; 31).
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Molecular characterization of RyRs and modulators
Identifying mechanisms of aberrant calcium release with age in aging rat SCG
In light of the observable alteration in rapid and spontaneous refilling in chapter 2,
and previous studies demonstrating a decline in SERCA function, it is possible that
calcium release can also be altered as a result. In chapter 3 we have molecularly
characterized the putative mechanisms contributing to our previous functional studies.
Aging and genetic expression ryrl, 2 and 3
It has been demonstrated that the ryrl is predominantly expressed in skeletal
muscle, ryr2 is predominantly expressed in cardiac muscle and ryr3 is expressed in many
tissue types, but predominantly in brain and neurons [Reviewed in (11; 12; 18; 19; 23;
27; 28)]. Numerous studies have shown differential genetic expression oi ryr

2 and 3

isoforms in various neuronal models (9; 16; 21; 22; 32). However, to our knowledge this
is the first report of on the genetic expression of ryrl, 2 and 3 in the SCG model. In this
study, transcriptional analysis of adult rat SCG demonstrated the transcription of both
ryr2 and ryr3. However, there was no transcription of ryrl detected in the SCG using
total RNA concentrations up to 1 microgram, yet it was detectable in substantial quantity
in our positive control, the cerebral cortex. This data does not necessarily suggest that
RyRl is not expressed in adult rat SCG, but suggests that it is not the major isoform of
the adult rat SCG and may be detected using higher concentrations of RNA.
Transcriptional analysis of the ryanodine receptors in the SCG demonstrates that
ryr2 and ryr3 are the major ryr transcripts present in SCG and their gene products may be
responsible for calcium release from the SER stores. The ryr2 gene expression did not
change with age suggesting that ryr2 levels remain stable during late maturation and
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senescent aging. However, mRNA coding for the ryr3 isoform increased from 6 to 12
months and then significantly declined from 12 to 24 months of age. To our knowledge
this study is the first to show that there appears to be a late maturational increase in the
ryr?> isoform with a subsequent decline with senescence (Figure 4.2). These results do
not necessarily differentiate between changes in genetic expression or altered stability of
the mRNA in the age groups. Thus, both possibilities may explain the results. Overall, the
data suggest that the contribution of ryr?) to the RyR3 protein levels and ultimately
calcium signaling in the SCO may change with age while the contributions provided by
RyR2 levels remain stable.
Aging and protein levels ofRyR2, RyR3 and modulatory nNOS
Changes in genetic expression alone do not necessarily hold a complete
explanation for altered RyR protein levels or regulation of the RyR’s. Thus, we measured
RyR2 and RyR3 protein levels using an ELISA assay and normalized to the stable marker
GAPDH. Following a similar pattern mRNA RyR2 protein levels were not changed in
any age groups. The lack of a change in RyR2 protein levels in any age group suggests
that this isoform may remain stable and functional throughout the adult life span. On the
other hand the turnover rate of the RyR2 in neuronal cells was not evaluated, which may
possibly affect protein function. For example in muscular tissue, the turnover rate of the
RyR was decreased by 25% in the aged rats in comparison to the younger rats (10). RyR
turnover has not been evaluated in SCO and may change with age. Any alterations in
turnover rate may have an impact on the RyR2 protein function such as increased
oxidation and protein damage in the SCG.
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In contrast to RyR2, RyR3 protein levels increased from 6 to 12 months and then
declined at 24 months (Figure 4.2). However, the decline at 24 months was not
significantly smaller than at 6 months. Thus, a straight-forward conclusion as to
functional consequences of this age-related decline is difficult to make. We have shown
that caffeine-evoked release of calcium declines with age (33). As caffeine-evoked
calcium release offers a measurement of the functional capacity of the RyR sensitive
stores, it is difficult to interpret a mechanism based on the alterations in RyR3 protein
levels alone. However, the function of the RyR’s also depends on SER calcium filling
levels as well as the modulation of the RyR’s. We have shown that SERCA function
declines in the SCG (26) and that basal levels of [Ca2+]i also decline with age (33). Thus,
filling levels of the SER may also be compromised which may alter the functional
capacity of the release mechanism. In addition, protein levels do not necessarily fully
correlate with protein function as some may undergo post-translation modification and
may require accessory proteins and modulators to regulate their function. It has been
reported that RyR function can be influenced by several factors, including
phosphorylation, binding proteins, calcium levels, and nNOS which modulates cADPr
levels and in turn modulates RyR’s [Reviewed in (2; 6; 8; 14; 20)].
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To evaluate if there are changes in selected modulators of the channels, we measured the
levels of total phosphorylation. Total phosphorylation of RyR channels was not altered
with age (Figure 4.3). These data suggest that changes in steady state phosphorylation
and hence alteration in the regulation by this mechanism is not necessarily occurring.
NO synthesized by nNOS has been shown to be implicated in modulating calcium
in neurons (8). It is involved in the production of nitric oxide and can be directly
regulated by calmodulin, a calcium binding protein. It is part of the signal transduction
pathway responsible for cADPr synthesis, which directly affects the activity of the
ryanodine receptors and modulates release of calcium from SER stores. We have
observed that the addition of nitric oxide donors increased caffeine-induced calcium
release in SCG cells. Our data demonstrated that with advancing age, nNOS protein
expression increases from 6 to 12 months and significantly declines from 12 to 24 months
(Figure 4.3). In addition, as nNOS activity modulates cADPr levels, which in turn
modulate RyR activity it may reasonable to speculate that these data may possibly
suggest that cADPr levels may also decline with age. As there appear to only be two
RyR’s contributing to calcium release in the SCG, overall, the age-related decline in
RyR3, coupled with a decline in nNOS levels may in part provide an explanation for the
decrease in RyR mediated calcium release with age as noted in our previous study (33).
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1. The ability to rapidly refill the
caffeine-inducible calcium stores
in rat SCG is altered with age.

2. There is an age-related
decline in the rate of rise of
K+-evoked [Ca2+]i transients.
3. The efficiency of K+ to refill
[Ca2+]i stores declines with age.
4. The ability to
spontaneously refill the
caffeine-inducible calcium
stores in rat SCG is altered
with age.
5. RyRl is not the
predominantly expressed
isoform in adult rat SCG.
6. RyR2 and RyR3 are the
predominantly expressed
RyR isoforms in adult rat
SCG.

t

10. Phosphorylation of the
total RyRs does not change
with age.

SCG and
aging

1
7. RyR2 genetic and protein
levels remain constant
throughout the aging
process.

9. nNOS levels which
modulate ryr2 and ryr3 in
adult rat SCG changes with
advancing age.
8. RyR3 genetic and protein
levels changes with
advancing age.

Figure 4.4. Findings of this study (the big picture)
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